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Foreword
The observations that form the basis of this thesis were made 
mainly between 1969 and 1971 at the MRC Mineral Metabolism Unit, 
Leeds, under the directorship of Professor B.E.C. Nordin. The work 
led on naturally from a study of urine acidifying mechanisms in a 
group of patients, most of whom had renal stones. The patients 
generally had a substantial reduction in glomerular filtration rate, 
a urine acidifying defect, and a number had clinically apparent 
osteomalacia. However, the association of the osteomalacia with 
the chronic metabolic acidosis seemed at least as strong as with 
the degree of uraemia, raising again the old question of whether a 
causal connection existed between acidosis and renal bone disease.
Due especially to the beautiful work of David Fraser in 
Cambridge we now know that most creatures exposed to direct sun- 
light have evolved a metabolism that far from accumulating Vitamin D, 
tends rather to inactivate and excrete it, presumably to reduce the 
risk of toxic effects. Perhaps for similar reasons, the hydroxylating 
enzyme in the kidney seems to have a relatively limited capacity for 
increasing production of 1,25-dihydroxycholecalciferol. The material 
is so potent that the organism is probably better served by a system 
that is less, rather than more, able to generate it in large quantities 
when stimulated. A greater capacity for 1,25-dihydroxycholecalciferol 
production would require the existence of a stronger counter-regulatory 
mechanism than appears to be provided by calcitonin, for example. 
Thus if evolution has given any consideration to the patient with
chronic renal failure, it is to ensure protection against toxic 
hypercalcaemia, and it is clear that the effects of 1-hydroxylation 
failure of Vitamin D may appear in non-fatal uraemia. This does 
not mean that acidosis is irrelevant, however, because any adverse 
effect that it might have would be of critical importance in a 
situation where synthesis of the active metabolite of Vitamin D 
were already impaired.
In this study, two terms have been used in a general sense. 
The first is renal bone disease, synonymous with osteodystrophy, 
and simply implying the presence of a detectable bone abnonnality 
related to the renal failure. The precise pathology has been 
considered when appropriate. The second term is Vitamin D, which 
may refer to any of the commonly prescribed analogues, although 
ergocalciferol has usually been used. Dihydrotachysterol has been 
distinguished in the text where necessary. In the figures, open 
circles always designate data from patients with normal plasma 
alkaline phosphatase levels, and closed circles refer to data from 
other patients. All patients in the study gave their informed consent.
Finally, it is a necessary and pleasant duty to acknowledge 
the enthusiastic help of many graduates and technicians at the 
MRC Unit in Leeds; the Department of Medicine, Sheffield Royal 
Hospital; and Strangeways Research Laboratory, Cambridge.
CONTENTS
Introduction
Review
1
6
Concepts
Abbreviations
Definitions and Concepts. Filtered load - Calcium 
Excretion - Renal Threshold - Phosphate Excretion 
the Steady State - Calcium Pool - Isotopic Bone 
Mineralisation Rate - Osteomalacia - Quantitative 
Bone Histology.
16
18
Methods
Biochemistry - Calcium Absorption - Metabolic 
Balance Studies - Bone X-ray Measurements - Iliac 
Crest Biopsies - Quantitative Bone Histology - 
Clinical Material.
30
Results
Section I, 
Section II.
Section III. 
Section IV.
Section V. 
Section VI.
Cases with Florid Renal Osteomalacia
Identification of Presence of Bone Disease 
in Chronic Renal Failure - Alkaline 
Phosphatase and Plasma Calcium and 
Bicarbonate - Bone X-rays and Plasma 
Calcium and Bicarbonate.
Plasma and Urine Calcium - Plasma Calcium 
and Phosphate - Plasma and Urine Phos- 
phate.
Calcium Absorption and Plasma Creatinine 
and Bicarbonate - Metabolic Balances - 
Effect of Acidosis.
Isotope Bone Turnover Rate - Effect of .. 
Acidosis.
Quantitative Bone Histology and Alkaline 
Phosphatase, and Plasma Calcium and 
Bicarbonate - Mineralised Bone Mass
41
46
Section VII. The Calcaemic Action of Vitamin D
52
57
61
65
72
Section VIII. Acidosis and Experimental Rickets .. .. .. 75
Discussion and General Summary
Osteomalacia and Osteoclasis - Bone Resorption - .. .. 77 
Plasma Calcium Homeostasis - Alkaline fhosphatase.
Appendix .. .. .. .. .. .. .. .. .. .. .. .. .. 91
Tables
CHAPTER 1
Introduction
When considering the disordered metabolism of bone that 
occurs in chronic renal failure, it is perhaps to Kodicek and his 
colleagues that we owe the greatest debt. In 1970 they showed that 
under normal conditions the calciferol molecule is altered by the 
body to successively more active compounds, and that the final stage 
in the process takes place in the kidney (Fraser & Kodicek, 1970). 
Furthermore, the synthesis of the final active metabolite, 1,25- 
dihydroxycholecalciferol, is subject to feed-back control probably 
with parathyroid hormone acting as mediator (Fraser & Kodicek, 1973). 
Earlier de Luca (1969) had suggested that a polar metabolite of 
Vitamin D, readily detectable in the serum of normal individuals, 
was absent from patients with chronic renal failure, and that this 
metabolite was more active in promoting gastro-intestinal transport 
of calcium than the parent substance; but the material, 25-hydroxy- 
cholecalciferol was not greatly more potent than calciferol itself 
(Blunt et al. 1968) and moreover was synthesized in the liver 
(Avioli et a!. 1967), so that while this must rank as an extremely 
important piece of work, it failed to explain the Vitamin D resistance 
of chronic uraemia, nor did it involve the kidney in Vitamin 0 
metabolism.
In spite of these advances the picture is not entirely clear. 
1,25-Dihydroxycholecalciferol is a potent calcaemic hormone but 
there is no clear evidence that it is the major anti-rachitic agent, 
and there is some information suggesting the contrary (Omdahl et al. 
1971). Furthermore, while malabsorption of calcium is invariably 
found in chronic renal failure when the glomerular filtration rate 
is less than 25 ml/minute, osteomalacic bone is not necessarily
present. It also appears that the synthetic compound 1-hydroxy- 
cholecalciferol, thought to be converted to 1,25-dihydroxychole- 
calciferol, is without any dramatic effect on renal osteomalacia 
or rickets, although calcium absorption is undoubtedly improved.
In the past the frequent co-existence of a severe metabolic 
acidosis and renal bone disease has led many to suspect a causal 
relationship and earlier authors (Holt et a!. 1925; Parsons, 1927) 
suggested that the mechanism might lie in the sensitivity of the 
ionic product of calcium phosphate to change in the prevailing 
hydrogen ion concentration. Albright (1937) in particular emphasized 
the importance of acidosis, though he interpreted differently the 
way in which it might act. He believed that in a state of metabolic 
acidosis, calcium would be excreted as an available cation in place 
of ammonium, leading ultimately to a decreased rate of mineralisation. 
Albright's concept has been contradicted by observations in many 
individual cases (Stanbury, 1967), but its simplicity has proved 
attractive and has continued to focus attention on the possible 
central role of acidosis in renal bone disease. Stanbury, on the 
other hand, has frequently stated that bone disease and acidosis 
are independent consequences of uraemia, but are not causally related. 
There is no doubt, however, that acidosis may affect calcium meta­ 
bolism (Litzow et al. 1967) and a number of reports suggest that 
healing of osteomalacia may be more easily achieved if the acidosis 
is corrected (Stanbury, 1962).
Hypocalcaemia is the other common biochemical feature of renal 
osteomalacia (Parsons, 1927; Stanbury, 1967), and is generally 
believed to be of importance in its development. However,
mineralisation of rachitic bone can occur with Vitamin D therapy 
prior to correction of the hypocalcaemia (Stanbury, 1967) and, 
while accepting its statistical association, Stanbury questions its 
role in the pathogenesis of bone disease.
A syndrome exists therefore where renal osteomalacia or rickets, 
a metabolic acidosis, and sustained hypocalcaemia frequently co-exist 
but their inter-relationships are obscure. This work was undertaken 
to establish, firstly, what part, if any, is played by acidosis in 
the development of renal bone disease - whether osteomalacic or 
parathyroid induced - and secondly, whether the acidosis in any way 
contributes to the development of hypocalcaemia. It remains possible, 
but not certain, that the hypocalcaemia may itself influence the bone 
disease and some consideration is also given to this question.
The development of the study
While studying a group of patients with chronic pyelonephritis 
it became clear that a number of them with a particularly severe degree 
of metabolic acidosis due to a urinary acidification defect acquired 
as a result of the infection (Cochran et al. 1968) also had clinical 
osteomalacia or rickets. This was rarely seen in patients with 
primary glomerular lesions whose acidosis was generally milder except 
in the terminal phase of their illness. This observation again 
emphasized the strong association between acidosis and renal osteo- 
malacia and prompted the investigation of a group of fifty patients 
with stable chronic renal failure. The investigation v/as intended 
to determine the importance of various factors in the aetiology of 
the bone disease and it was therefore first of all necessary to
establish which patients had bone disease and which did not. The 
patients were therefore separated into those with normal and those 
with abnormal plasma alkaline phosphatase levels. The validity 
of this separation is discussed with respect to standard bone x-ray 
measurements and quantitative bone histology. It becomes apparent 
that the raised alkaline phosphatase level indicates an osteomalacic 
process whereas reduction in the standard bone x-ray measurements 
reflects parathyroid mediated bone resorption. Analysis of the 
relationship between the bone x-ray measurements and the various 
biochemical parameters suggests an association between reduction in 
cortical bone and hypocalcaemia, and between acidosis and both the 
presence of osteomalacia and hypocalcaemia. These data were further 
interpreted in the light of quantitative bone histology carried out 
on iliac crest biopsies. Calcium absorption was measured by a 
radiocalcium absorption test and the influence of acidosis on 
absorption is discussed. The kinetics of bone turnover in chronic 
renal failure were also investigated by means of metabolic balance 
studies and radioisotope techniques. In this way mineralisation and 
resorption rates were determined in a number of patients, and 
comparisons made between the acidotic state and non-acidotic state. 
Since hypocalcaemia seemed to lead to bone resorption, emphasis has 
been given to consideration to certain factors influencing plasma 
calcium levels in chronic renal failure, and in particular the 
mechanisms of action of acidosis and Vitamin D have been examined.
The causes of acidosis in chronic renal failure are well known, 
but the information presented here provides some explanation for 
the hypocalcaemia and it is possible to discuss the relative
contributions of acidosis and hypocalcaemia to the osteomalacia 
and hyperparathyroidism of renal bone disease.
CHAPTER 2
Review
The association of bone deformities with renal disease was first 
noted by Lucas who in 1883 published a paper entitled "A Form of 
Late Rickets Associated with Albuminuria". However, this author 
believed that both the rickets and the albuminuria were consequences 
of puberty, and assumed that the condition would stabilize or improve. 
At about the same time Davis-Colley described the case of thirteen 
year old girl with marked bone changes who subsequently died of renal 
failure (Davis-Colley, 1884). There followed three separate case 
reports of renal failure in young children with rickets but at the 
time the presence of bone disease in infancy was not considered in 
any way remarkable (Hellendall, 1897; Sequeira, 1901; Sawyer, 1903). 
In reporting a series of children with renal failure and hypertensive 
retinopathy, Nettleship (1903) mentioned the case of an older child 
with congenital renal disease and bowing of the tibiae.
In 1911 Fletcher described a six year old boy with marked genu 
valgum and renal disease as evidenced by polyuria, albuminuria and 
bilateral palpable kidneys. In the discussion, Fletcher did not 
particularly emphasize the association of bone and renal disease 
but he is generally credited by his own contemporaries for recognizing 
some aetiological connection, and about this time the term renal 
rickets began to appear. Miller and Parsons (1912) and Naish (1912) 
observed that rickets was a not uncommon complication of chronic 
renal disease in childhood. During the next 15 years a number of 
case reports on the subject were published, and Barber, in particular, 
clarified the clinical features of the disease in a series of papers 
(Barber, 1913, 1918, 1920, 1921, 1922 and 1926).
During this period there was considerable activity directed
towards understanding the nature of nutritional rickets and a number 
of hypotheses were proposed to explain the phenomenon. Firstly it 
had been shown that Vitamin D deficient rats would develop rickets 
when they were fed either a low calcium - high phosphorus or a low 
phosphorus - high calcium diet. As a result, it was suggested that 
there were two types of rickets: one form consequent upon a relative 
calcium deficiency, and the other due to a relative phosphorus 
deficiency. This theory was not easily reconciled with that of 
Howland (1923), who put forward the idea that serum and extracellular 
fluid formed a saturated solution in which the calcium phosphate of 
bone was in dynamic equilibrium with the dissolved salt.
SCa"1"1" + 2P04 " ^f Ca3 (P04 ),
It was further suggested that since bone was a relatively inactive 
tissue there would be low local concentrations of carbonic acid which 
would tend to favour the deposition of calcium phosphate.
3Ca++ + 2HP04 + 2HCO'3 ^± 2CaHP04 + Ca(HC03 ) 2
2H 2 C03
These ideas were put forward on purely theoretical grounds but 
Howland stated that they could be supported by clinical observations, 
and introduced the idea that a useful approximation could be made 
simply by considering the numerical calcium x phosphorus product when 
the concentration of each in serum was expressed in mg/100 ml. Thus
in the normal child products of 50 or 60 were obtained, but "when the 
product was below 30, rickets was invariably present. Hith products 
between 30 and 40 rickets was usually present and demonstrable healing 
occurred when the product was above 40". Howl and must have met a 
number of cases which were not compatible with his physico-chemical 
theory for he later suggested that other factors might be involved 
(Shipley et_aj_. 1926). He stated "the process is not one of simple 
precipitation; it depends upon the activity of living tissue". 
However, he went on to say that the mineralisation must depend upon 
the concentration of calcium and phosphorus excee'ding a certain minimum 
value in the bone-forming cells. (These views were later echoed by 
Cochran and Nordin (1969) who published a small series of cases of 
renal osteomalacia and suggested that either the ionised calcium or 
phosphate, or both, were reduced in the serum in these patients). 
Another theory, which later gained a certain degree of favour was 
that of Robison (1926). He believed that by producing the enzyme 
alkaline phosphatase, the osteoblasts hydrolysed the phosphoric 
esters of the extracellular fluid and brought about a local increase 
in phosphate concentration, thereby leading to a local highly super- 
saturated solution of calcium phosphate with resulting precipitation 
of the salt. However, this hypothesis was quite impossible to 
substantiate and remained controversial. Although Howl and had encoun- 
tered difficulty in explaining the presence of nutritional rickets 
in certain cases, the problem appeared to be resolved by the suggestions 
of Holt et al. (1925). These authors pointed out that even in a super- 
saturated solution, calcium phosphate precipitates out relatively 
slowly and the speed with which this occurs decreases markedly as the
ion product falls toward the solubility product. Thus, although 
in active rickets an apparently supersaturated solution might occur 
they believed that calcification was so severely delayed that osteoid 
would gradually build up without proper mineralisation. Pathologically 
delayed mineralisation could only occur in this way in growing bone 
and they pointed out that in normal adult life, after growth had 
finished, the concentrations of calcium and phosphorus could be 
similar to those found in active rickets in infants.
As these concepts developed it was natural that most of the 
discussion and speculation regarding renal rickets was concerned 
with chemical changes in the blood. Halverson in 1917 showed that 
hypocalcaemia was a common accompaniment of chronic renal failure 
and this was abundantly confirmed in further studies by Denis et a!. 
(1923), de Wesselow (1924), and Rabinowitch (1925). Greenwald (1915) 
had earlier reported an elevated plasma phosphate in chronic renal 
failure and his observation was confirmed and extended by Howland 
in 1916. This general recognition of a reduced or normal plasma 
calcium and hyperphosphataemia in renal failure led to controversy 
concerning the obviously defective mineralisation when considered 
in the light of Rowland's hypothesis. These difficulties appeared 
to be resolved, at least in part, by considering the effect of the 
hydrogen ion concentration on physico-chemical equilibrium. Thus 
Freudenburg (1923) pointed out that the ion product of calcium 
phosphate would fall rapidly with any tendency to acidosis. Parsons 
(1927) in particular strongly emphasized the importance of the 
metabolic acidosis in the development of renal bone disease with a 
clear clinical, histological and biochemical account of a small
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series of patients. However, Parsons also held the seemingly 
inconsistent view that the ratio of calcium to phosphorus in the 
blood was of importance in normal mineralisation, which he believed 
could not take place in the presence of a greatly elevated serum 
phosphate. This idea had arisen as a result of the experimental 
studies in animals and because of the widely held view that calcium 
would not be deposited in the skeleton when it was required in the 
serum to prevent the development of tetany. Commenting on the 
failure of anti-rachitic foodstuffs or ultra-violet light to cure 
renal rickets, Parsons agreed with Shipley (1926) that some "endogenous 
factor" must be present to account for this resistance to conventional 
therapy.
Some years later, Mitchell, in a long review of the subject 
(Mitchell, 1930) expressed doubts about Parsons' view that a reduced 
ion product existed in acidosis but this was clearly in order to 
advance an alternative theory, which was however based more on conjec- 
ture than the careful studies of the earlier workers. Nonetheless, 
Mitchell agreed that acidosis was of importance and this factor there- 
fore continued to play a central role in th r thinking of workers in 
this field. He quoted the experiments of Haldane (1923) and Nelson 
(1928) to show that acidosis led to mobilisation of tissue phosphate 
which was then normally excreted in the urine, but in renal failure 
he suggested that the phosphate could only be excreted via the gut 
where it would precipitate dietary calcium. In this way he attributed 
the development of bone disease entirely to the malabsorption of 
calcium.
An important concept was introduced in 1936 by Fanconi, who
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pointed out that the renal tubule could be defective in secretion 
or resorption and thus allow wastage of essential materials. He 
described a syndrome of rickets associated with hypophosphataemia, 
metabolic acidosis and renal glycosuria without evidence of marked 
glomerular failure. The hypophosphataemia offered an apparently 
simple explanation for the failure of bone mineralisation and this 
relatively rare form of rickets unfortunately focussed attention away 
from the uraemic variety to such an extent that the existence of the 
latter began to be doubted. Thus Albright dogmatically affirmed that 
the disease in question was osteitis fibrosa (Albright & Reifenstein, 
1948) and dismissed without comment the histological evidence of 
osteomalacia so clearly shown by Foil is and Jackson (1943). According 
to Albright, three main types of renal bone disease were found:
1. That associated with chronic glomerular failure - regarded 
as osteitis fibrosa.
2. That associated with renal tubular acidosis without glomerular 
insufficiency - a true osteomalacia or rickets.
3. That associated with primary hypophosphataemia as a manifestation 
of the Fanconi syndrome - a true osteomalacia or rickets.
In all cases, the presence of acidosis was considered of prime 
importance for Albright believed that calcium was excreted in the 
urine as an available cation in place of ammonia. He postulated 
that this led to hypocalcaemia which was however compensated by a 
moderate degree of parathyroid hyperplasia, this secondary hyper- 
parathyroidism in turn causing phosphaturia and hypophosphataemia
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provided glomerular function was adequate. The calcium x phosphorus 
product thus decreased and mineralisation was delayed. In the 
presence of glomerular failure, hypophosphataemia could not occur, 
and the state of uncompensated hyperparathyroidism led to the 
development of osteitis fibrosa.
Nonetheless, there was general acceptance that osteonialacia 
could occur with general renal failure, and many believed that the 
cause was some accumulated metabolite, though McCune et aj^ (1943) 
denied this. This idea was revised by Yendt and Howard (1955) when 
they reported evidence of an inhibitor of calcification in uraemic 
serum, using a technique similar to that used by Rowland thirty 
years before. This work was of great interest at the time but it 
has not been confirmed and its validity is consequently open to some 
doubt.
Stanbury has made careful observations correlating the clinical, 
histological and metabolic features of renal bone disease in several 
large series of patients (Stanbury & Lumb, 1962; Lumb & Stanbury, 
1966; Stanbury, 1968a, b) and strongly criticised the views of Albright, 
pointing out that these have been contradicted by observations in 
many individual cases (Stanbury, 1962). Furthermore, Stanbury has 
frequently asserted that acidosis is merely a common accompaniment 
of renal bone disease but does not contribute to it.
A number of experiments have been carried out showing that bone 
contains a simple calcium carbonate fraction which may be eluted by 
ammonium chloride in vitro or by chronic acidosis in vivo 
(Pellegrino & Biltz, 1965). It has also been suggested that the 
mineral structure of bone is in the form of a lattice which may
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become relatively calcium deficient in certain circumstances 
(Richelleet al. 1965). Yet other work has shown evidence of an 
amorphous calcium phosphate fraction which is considered to be 
more easily exchangeable than the mineral of structural bone 
(Watson & Robinson, 1953; Posner, 1969). It may be argued however 
that whether or not these observations are correct, the mineral 
phase under discussion is always a labile moeity which is structurally 
distinct from the bulk of the bone tissue; and a leeching out of 
mineral would in any case be most unlikely to give the morphological 
picture of osteomalacia. Litzow et al. (1967) demonstrated that the 
acidosis of uraemia leads to a chronic calcium loss both in the 
faeces and urine, and Lemann (1969) states that over a period of 
time this must contribute to the bone disease of chronic renal 
failure. Stanbury's own data show that correction of the metabolic 
acidosis in chronic renal failure results in a slight net positive 
shift in the calcium balance (Stanbury, 1962) but as he points 
out in another context (Stanbury, 1968a), this does not necessarily 
mean that correction of the abnormalities or mineralisation would 
follow. Nonetheless, it does show that acidosis affects calcium 
metabolism in a fundamental way and the work is amply supported 
by the studies of Lemann et al. (1967) and Litzow et al. (1967). 
Using semi-synthetic diets, they carried out metabolic balances 
before and after correction of the acidosis in uraemic patients, 
and examined the effect of induction of acidosis in normal subjects. 
Acidosis was associated with a decrease in gastro-intestinal 
absorption and renal tubular reabsorption of calcium. Further 
evidence implicating acidosis in the genesis of renal osteomalacia
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has come from certain reports where rachitic lesions have apparently 
healed following correction of the acidosis alone (Foss et al. 1956; 
Green & Boyd, 1959; Hossain, 1970; Wrong, 1971; Bishop & Ledingham, 
1972). Most, though not all, of these patients had a degree of 
acidosis that was out of proportion to the glomerular lesion as a 
result either of an acquired form of renal tubular acidosis or 
ureterosigmoidostomy. (It is possible to speculate that the renal 
tissue required for the synthesis of the active principal of Vitamin D 
is intact in such cases, but that this synthesis, or the end organ 
response, is inhibited by the acidosis).
As far as the plasma concentrations of calcium or phosphate are 
concerned, many clinicians have accepted the view that they determine 
the state of mineralisation. There are a number of studies where 
correction of the biochemical disorder alone without the use of 
Vitamin D appears to have improved nutritional or renal rickets 
(Fraser et al. 1958; Fraser et al. 1959; Cassimos et al. 1963; 
Snodgrass & de Wardener, 1969). However it is well known that nutrit- 
ional rickets may begin to heal simply after hospital admission even 
when attempts are made to provide the patient with his usual diet 
and renal rickets may undergo spontaneous cure (Parsons, 1927). 
Fletcher et al. (1963) failed to improve the bone lesions of a group 
of patients with renal osteomalacia after correction of the hypo- 
calcaemia by feeding calcium salts. It is also possible, though rare, 
for florid renal rickets to exist in the presence of hypercalcaemia 
without hypophosphataemia. In one such case (see appendix: case I) 
the bones were densely mineralised yet classical rachitic changes 
persisted at the diaphysis. In another case where severe osteomalacia
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resulted from renal hypophosphataemia (see appendix: case II), 
after prolonged administration of phosphate, there was some slight 
improvement in mineralisation both radiologically and histologi- 
cally but the latter showed no evidence that a real cure was taking 
place. Much of the mineral deposition was irregular rather than 
along a normal calcification front, and the general appearance of 
the trabeculae remained disorganised. Emphasising this point, a 
small series has been published showing that simple correction of 
the biochemical lesion in renal osteomalacia is associated with 
patchy, abnormal mineralisation (Eastwood et al. 1974).
It does seem possible that in certain circumstances rickets 
may be aggravated by low mineral concentrations in the plasma, and 
these two cases suggest that some mineral deposition may occur when 
correction of the biochemical lesion is achieved, but this is not 
to say that such mineralisation is necessarily normal or that it 
represents true healing.
CHAPTER 3
Concepts
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ABBREVIATIONS. DEFINITIONS AND CONCEPTS
Abbreviations
GFR
GF
ECF
Ca/Cr
Ca r
P/Cr & P£ 
TmP
Cti
m
Glomerular filtrate rate, ml/min.
Glomerular filtrate.
Extracellular fluid.
Ratio of calcium concentration to creatinine
concentration in any urine sample. The Ca/Cr
is a measure of absolute calcium excretion in
an individual since excretion of creatinine in
the urine proceeds at a constant rate.
Urine calcium excretion, expressed as mg urine
calcium derived from 100 ml of filtered plasma
water, i.e. mg/100 ml GF.
Refer similarly to phosphorus excretion.
Maximum tubular reabsorptive capacity for phosphorus.
When expressed in mg/100 ml of GF it is equal to
the theoretical phosphate threshold.
Calcium absorption expressed as the fraction of the
dose of calcium presented to the gastrointestinal
absorptive surface that is absorbed per hour. A
tracer dose of radio-calcium is used in 20 mg of
calcium as calcium chloride.
Bone mineralisation rate, measured isotopically and
expressed as the amount of calcium entering the bone
per unit body weight of the individual per day, i.e.
ng/kg/day.
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r - Bone resorption rate estimated indirectly by the 
difference between the mineralisation rate and the 
calcium balance of the individual and expressed in 
mg/Kg/day.
CA/TA - The ratio of the cross-sectional area of the cortex 
to the total cross-sectional area of the second 
metacarpal, mid-way along the shaft of the bone.
MTW - Total width of the second metacarpal at the mid-point, 
cm.
OHP - Urine total hydroxyproline, mg/24 hours.
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Definition and Concepts
Filtered load
The filtered load is the unit quantity of material filtered 
at the glomerulus. If expressed per unit time, it equals the 
product of the glomerular filtration rate (GFR) and the concentration 
of the substance in question in the ultrafiltrate. Alternatively, 
since GFR is difficult to measure accurately, a unit volume of filtrate 
may be considered. The filtered load can then be expressed in mg/100 
ml of filtrate, which is the same as the plasma water concentration. 
This has obvious advantages, provided the excretion and tubular re- 
absorption are related to that same standard volume of glomerular 
filtrate (GF). If the substance in the plasma is partly protein- 
bound, this has to be taken into account. 
Calcium excretion
As with filtered load, calcium excretion can be expressed in 
more than one way. The absolute rate of excretion is usually expressed 
in mg/min. However, this leads to inaccuracies since exact timing 
of bladder emptying is required though these inaccuracies are of less 
significance when prolonged collections are made, for example, over 
a 24 hour period.
Another method of expressing the absolute rate of excretion is 
to relate the concentration of calcium to that of creatinine in the 
same urine sample. The justification for this is that in any individual, 
the rate of excretion of creatinine is relatively constant throughout 
the day and will only alter with change in muscle mass, the site of 
creatinine production. A fall in GFR will raise the plasma concen- 
tration of creatinine but the same amount will be excreted per day
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in the urine. The urine calcium/creatinine ratio (Ca/Cr) is thus 
a measure of absolute calcium excretion which does not depend on 
timed urine samples. The objection to this way of expressing 
calcium excretion is that the rate of excretion of creatinine 
varies from individual to individual, so that a healthy man may 
excrete 1500 mg/24 hours, while a malnourished child may produce 
only 500 mg/24 hours. This would obviously affect comparison of 
the Ca/Cr in the two cases. However, most individuals produce 
800 - 1200 mg/24 hours and in practice the Ca/Cr provides a very 
useful measure of instantaneous calcium excretion in absolute terms.
Calcium excretion may also be related to the glomerular filtrate. 
When a unit volume of plasma is filtered, materials which are of 
physiological importance to the body are largely reabsorbed, and a 
small amount excreted in the urine. Excretion and filtration must 
be considered in the same terms and it then becomes possible to 
compare the calcium excreted per 100 ml of GF - termed the Ca^ - 
directly with the plasma ultra-filtrate concentration. This is a 
relatively simple measurement, since creatinine provides a marker 
of glomerular filtrate. Thus the plasma creatinine concentration 
denotes 100 ml of glomerular filtrate and the volume of urine that 
contains the same amount of creatinine will be derived from that 
unit of filtrate. The calcium excreted per 100 ml of GF may be 
calculated knowing the urine calcium and creatinine concentrations 
in a random sample and the simultaneous plasma creatinine concentrations.
Cr Thus : Vu = V()1 ume Qf Gp
P
V.Cau
Calcium (mg) excreted in V = ———
100
20
Calcium excreted/100 ml of GF,
Cr
u
i.e. Ca,- =
when Cr = urine creatinine concentration, mg/100 ml
Cr = plasma creatinine concentration, mg/100 ml
Ca = urine calcium concentration, mg/100 ml
V = volume of urine, ml.
The relation between the filtered load of calcium and the 
calcium excretion per 100 ml of GF has been established in normal 
subjects (Peacock & Nordin, 1968). In practice it can be assumed 
that the ultrafiltrable calcium is directly proportional to the 
plasma concentration and it is therefore possible to consider urine 
calcium relative to GFR (Car) as a function of plasma calcium 
concentration. The normal range for Ca/Cr is 0.05 - 0.15; and for 
CaE , 0.05 - 0.17 mg/100 ml GF. 
Renal Threshold
Generally speaking, the urinary excretion of a substance is 
some direct function of the filtered load. However, below a certain 
value for filtered load, described as the threshold, the substance 
may virtually disappear from the urine owing to tubular reabsorption. 
The threshold level is therefore determined by the tubular handling 
of the substance.
5 4
O
O
* 2
ft!" 
1
0
Theoretical
Threshold
(TmP)
123456 
Plasma Phosphorus mg/100 ml
Fig. 1. The relation between filtered and excreted phosphate 
expressed per 100 ml of glomerular filtrate, showing the 
theoretical phosphate threshold, which is the same as the 
maximum tubular reasorption.
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Phosphate excretion
Urine phosphate excretion may be considered in exactly the same 
way as calcium excretion, but it has been examined from a number of 
view-points by different workers (Anderson, 1955; Nordin & Fraser, 
1960; Bijvoet, 1964; Nordin & Bulusu, 1968). Hhen phosphate excre- 
tion relative to GFR (P^) is related to the plasma phosphate concen- 
tration, it is found in normal subjects that as plasma phosphate is 
progressively elevated, urine excretion begins to rise at an increasing 
rate, until any further rise in the plasma level results in the same 
amount appearing in the urine. The phase of rising excretion rate 
represents splay, and the condition where each incremental rise in 
filtered load causes an equal rise in urine excretion is when the 
maximal tubular reabsorption rate has been achieved. Although the splay 
zone is a curve, it has been approximated to a linear function by 
Nordin and Bulusu (1968), who have established the relationship between 
phosphate excretion per 100 ml of GF for conditions where the state 
of maximal tubular reabsorption has not been reached. On the other 
hand, Bijvoet (1964) has examined by means of phosphate infusions 
the theoretical theshold, which is the same as the maximum tubular 
reabsorptive capacity relative to GFR (Fig. 1). Since most patients 
with renal failure are above the theoretical phosphate theshold due 
to a tendency to phosphate retention, the terminology of Bijvoet has 
been included in this study, and the state of tubular reabsorption 
of phosphate is therefore expressed as the theoretical phosphate 
threshold, TmP- It may be calculated knowing the plasma phosphate and 
the phosphate excretion per 100 ml GF (Pr)-
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Renal excretion and the steady state
The factors which influence the steady state in human physiology 
are frequently overlooked, and other factors, which may scarcely 
influence it, are sometimes considered of importance. There are two 
main ways in which the composition of plasma, and therefore extra- 
cellular fluid (ECF), is kept constant and both are concentration 
dependent. One mechanism is by the negative feed back control of 
endocrine release and the other is by means of a threshold which 
governs excretion, so that once the filtered load reaches a certain 
level, the surplus material is lost in the urine. The latter 
mechanism may be modified by the former. The kidney operates by 
filtering a relatively enormous amount of fluid per unit time and 
reabsorbing all but the surplus which is excreted, exact character- 
istics of reabsorption varying with different substances.
This method of retaining those materials that are of physiolo- 
gical importance applies to calcium and under normal conditions about 
98% of filtered calcium has to be reabsorbed in order to sustain a 
normal plasma level. The corollary of this is that a small defect 
in the function of the tubule could allow a major fall in plasma 
calcium to occur.
If calcium begins to enter the plasma at an increased rate, 
the concentration will tend to rise. The output in the urine cannot 
remain unchanged, however, otherwise the plasma calcium concentration 
would increase indefinitely. Being concentration dependent, output 
rises until a new equilibrium is reached with input and output equal, 
but at a higher level. The exact change in concentration that occurs 
following a change in input is determined by the relation between
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change in concentration and change in output, but there is always a 
tendency to achieve a steady state when intake and output become 
equal. This is not to say that the overall calcium balance, whether 
positive or negative, affects the plasma level, since in these situa­ 
tions calcium is simply passing via the blood into or out of the bone. 
Calcium pool
The calcium pool is the mass of calcium in the body that is 
available for immediate exchange or alternatively the volume of fluid 
in which that mass of calcium is distributed. It is made up of ultra- 
filtrable and protein-bound calcium in the plasma, calcium in the ECF, 
and a certain amount of calcium in the bone. Although the intra- 
cellular calcium concentration is extremely low, the intracellular 
fluid volume is large, and cellular calcium probably contributes to 
some extent to the pool size. 
Isotopic bone formation rate
The kinetics of bone formation using radioisotopes have been 
studied by a number of workers using conventional multiple analysis. 
There are a number of disadvantages to this form of calculation, 
particularly the difficulty in distinguishing between the calcium 
entering the skeleton as a simple exchange process and that being 
incorporated into newly formed bone. In seeking to develop a form 
of calculation which would satisfactorily allow for exchange processes, 
Burkinshaw et al. (1969) suggested that the progressive labelling of 
skeletal mineral by exchange processes could be likened to a continu­ 
ously expanding exchangeable calcium pool, and that such a process 
might be represented by a power function. Thus when the logarithm of 
plasma specific activity of radio-calcium is plotted against the
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logarithm of time, a linear decline in specific activity is found to 
occur during the first fifteen hours, with a more rapid fall during 
the next six days. Extrapolation of the linear part of the function, 
which represents the fall of plasma specific activity attributable 
to expansion of the exchangeable pool, onward to day 7 permits cal­ 
culation of the pool size at that time. This value is the reciprocal 
of the extrapolated specific activity. This pool size is multiplied 
by the actual observed serum specific activity on day 7, to yield the 
amount of radioactivity present in the exchangeable pool at that time. 
The total activity retained in the body at day 7 is estimated by whole 
body counting or by measuring the difference between the original 
dose of radio-calcium and that lost in the faeces and urine. The 
amount of radio-calcium calculated to be present in the exchangeable 
pool is then deducted from the total radio-calcium retained in the 
body at day 7 to yield the amount of activity attributable to 
mineralisation. This value is then divided by the integrated serum 
specific activity over the seven day period to yield the bone 
mineralisation rate. Bone resorption is calculated indirectly by 
subtracting the calcium balance from the mineralisation rate.
The technique, though complex, has proved useful in practice 
and has been shown by Burkinshaw and Marshall (1971) to have an error 
of the order of 8%. Nordin and his colleague (Bullamore et al. 1971) 
have used this method to examine bone turnover in patients belonging 
to various diagnostic categories and the model appears to be a 
satisfactory one. The patients in the present study are included 
in their data.
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Osteomalacia
Osteomalacia is generally defined as a histological entity. It 
is characterised by large areas of osteoid on the surface of a trab- 
ecular bone and these trabeculae are frequently thickened. Thus wide 
osteoid seams are taken to indicate advanced Osteomalacia, whereas 
narrow osteoid seams imply a lesser degree of the same process. 
However, the work of Frost (1967) has shown that Osteomalacia must 
also be considered in dynamic terms, and in this sense there is a 
decreased rate of osteoid production with a simultaneous, and often 
more severe, reduction in mineralisation rate. This means on the one 
hand that situations which cause high local rats of bone turnover 
cannot be considered osteomalacic in spite of the presence of numerous 
osteoid seams; and on the other, a situation where only narrow osteoid 
seams are present may be due to an extremely low rate of turnover, 
that is to say severe Osteomalacia in the terms of Frost. Osteomalacia 
may also be defined radiologically by the presence of Looser zones 
which are pathognemonic, but this appearance is caused by the failure 
of localised cortical fractures to heal, the fractures themselves being 
caused by weakening of cortical bone by parathyroid induced resorption. 
Quantitative Bone Histology
There are many ways of determining the volumes of bodies of 
irregular shape but the task becomes something of an enigma if the 
dimensions are microscopic and a further problem arises when it is 
impossible to isolate the object from the surrounding material. These 
difficulties were well known to geologists examining samples where 
one form of rock was embedded in another and it is the principles that 
they established which are now used for quantitative bone histology.
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Volume Estimation
The volume of the material in question approximates to the 
sum of the areas of material seen in serial sections. The problem 
then becomes one of measuring an irregular microscopic area. Point 
counting (Glagoleff, 1933; Chayes, 1954) enables this to be done 
relatively easily. If a grid containing a certain number of points 
is placed in the eye-piece of the microscope, then the number of 
points overlying the material under examination is proportional to 
the area of the material. The area measured (a) may therefore be 
expressed as a fraction of the total area of the grid (A).
Thus, i = H 
A N
where n is the number of points overlying the material, and N is 
the number of points on the grid.
The larger the number of points counted, the more accurate is 
the result and it has been found convenient to use a grid with twenty- 
five points, since this makes it easy to v/ork in percentages. A 
fifty point graticule makes counting difficult.
The volume (v) of the material in question can also be determined 
either in absolute terms or relative to the total volume (V) examined.
Thus, * - i =n
VAN
Surface Estimation
In bone, surfaces may be forming, resting or undergoing resorption. 
Forming surfaces are covered with osteoid and are therefore identified
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as such using suitable stains. Resting surfaces are mineralised, and 
have more or less smooth contours. Resorbing surfaces are represented 
by Howship's lacunae. Quantitation of these surfaces is only partly 
of value in studying the dynamics of bone turnover, since no assumptions 
can be made regarding the rates of formation or resorption at a given 
site. It is known from the work of Frost (1967) that calcification of 
osteoid proceeds at markedly different rates in different clinical 
states, and therefore the mere presence of an osteoid surface is no 
indication of the degree of activity taking place. In order to under- 
stand the true dynamics of bone formation, a marker is required to 
identify the quantity of bone laid down during a given time interval. 
In practice tetracycline is regarded as satisfactory and two doses are 
given at the beginning and end of a suitable time period. Tetracycline 
combines with the mineral as it is deposited and an envelope of tetra- 
cycline stained material therefore encloses all bone laid down during 
the time interval. During this study in patients in chronic renal 
failure, however, it was not found possible to use tetracycline reliably 
in this way. Occasional bands were formed where osteoid was presumed 
to have mineralised correctly but frequently the tetracycline appeared 
as blotches or stippling within the osteoid mass. This may signify that 
the abnormal mineralisation of osteomalacia does not only proceed 
more slowly than normal at a given site, as Frost (1967) has suggested, 
but that it is also completely disorganised and occurs at random through- 
out the osteoid. It is also true that, at least in some patients, 
abnormally high blood levels of tetracycline occurred and this may have 
influenced its deposition.
For the purposes of this study, therefore, surfaces have simply
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been identified as forming, resting or resorbing, and the proportion 
of each to the total surface has been estimated and expressed as a 
percentage. In addition, the number of osteoid surfaces with a distinct 
mineralisation front have been counted and expressed as a percentage 
of the total osteoid surface. The principles of surface counting are 
identical to those used for determining the volume, except that, since 
it is impractical to tell whether a grid-point overlies a line, which 
is how a surface appears in section, the graticule is made up of five 
parallel lines and the surface is counted if it intersects with any 
part of a line. A single graticule can be made of five lines, each 
divided by five equidistant points to serve both for volume and surface 
counting. 
Validity of Method
The accuracy of any length, area or volume measurement can be 
increased to almost any degree if only enough measurements are made. 
According to the Gaussian concept of probability, every reduction in 
the deviation to one-half its original value requires four times as 
many measurements.
With the present technique, forty-eight serial sections are cut 
and every third section is used. Four fields from every section are 
examined, so that with a 25 point graticule, a total area corresponding 
to 1600 points is scanned. With volumes of bone tissue occupying 
between 5% and 50% of the total, statistical tables indicate that the 
mean error should be less than 1%. The actual accuracy of the method 
may be tested in two ways: either statistically, or by determination 
of the reproduceability. When surface counting is carried out on the 
sixty-four microscope fields that are viewed, a range of results is
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obtained which are distributed according to a normal probability 
curve. The data may be plotted as a continuous summation curve and 
the median one-half of all counts found by drawing in the 25% and 75% 
probability lines (Figs. 2 and 3). This gives the amplitude (a) 
about the mean, from which the deviation (d) may be calculated:
d =     where N = the number of tests 
/ N
In this way, it can be shown that the probable error of this 
method is 5-9%. Direct testing of the reliability of the method by 
repeating estimations yields the same error.
CHAPTER 4
Methods
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Biochemistry
Extensive use has been made of the Technicon Auto-Analyser 
for biochemical determinations. Experience showed that this machine 
was not only convenient to use, but also gave reliable results of 
high reproduceability. In particular, it appeared to be considerably 
superior at estimating plasma calcium levels than any other device 
apart from the integrating atomic absorption spectrophotometer. The 
exact method used for both urine and plasma calcium estimations v/as 
that of Knowles (1968), and as far as plasma calcium is concerned, 
the variation of results was approximately j- 2%. The variation was 
somewhat greater for the estimation of urine calcium depending upon 
the concentration, but in general the method was extremely consistent. 
Plasma phosphorus and creatinine were measured by Auto-Analyser 
procedures N - 4a and N -lla respectively. The results for both 
varied approximately +^ 6% in plasma and in urine. An example of 
estimations of serum calcium, phosphorus and creatinine that were 
carried out and then repeated later in the same day are shown in 
Table 1. Similarly, seven urine samples were chosen on the basis of 
their different concentrations and calcium, phosphorus and creatinine 
were measured in each on ten random occasions. The results are 
presented in Table 1 with the mean and standard error. For present 
purposes, where consistency of results is necessary to enable changes 
to be detected and comparisons to be made, the Auto-Analyser is an 
extremely satisfactory instrument.
Arterial blood pH was measured in certain cases using standard 
Radiometer micro-electrode equipment on samples obtained by brachial 
artery puncture. The reproduceability of the method was extremely
oo
JS
re o
25
- 20
15
10
7-15
40
35
30
25*
: • t
••• u
7-20 7-25 
Plasma pH
7-3Q 7-35 7-40
Fig. 4. The relation between plasma bicarbonate and pH 
in patients with chronic renal failure. The associated 
plasma pCO is indicated.
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high, results varying by not more than +_ 0.004 pH units. The 
pC02 was measured on the same instrument. In general, however, the 
acid-base status of the patient has been expressed as the plasma 
bicarbonate measured by the Auto-Analyser procedure N - 21 a. The 
main justification for the use of plasma bicarbonate rather than the 
blood pH is that it avoids arterial puncture as well as the necessity 
of immediate measurement of the sample. When the arterial blood pH 
is compared with the plasma bicarbonate measured on the same sample 
using multiple observations on 20 patients with varying degrees of 
acidosis, a predictable relationship is found (Fig. 4) though there 
is a tendency for a decreased plasma bicarbonate to over-estimate the 
degree of acidosis as a fall in pCO^ due to compensatory hyperventilation 
offsets the reduction in plasma pH.
Urine total hydroxyproline was used as a measure of bone break­ 
down and was determined by the method of Grant (1964), adapted for use 
on the Auto-Analyser. The serum alkaline phosphatase was measured by 
Auto-Analyser method N 5, in which phenol liberated by hydrolysis of 
phenyl disodium phosphate is estimated colorimetrically. Chloride 
was measured by an E.E.L. chloride titrator. 
Calcium absorption
Calcium absorption was measured in the basal stage using a tracer 
dose of Ca in 20 mg of calcium given as calcium chloride, as 
described by Bullamore et al. (1970). The procedure was carried out 
with the patient fasting, when the calcium chloride with the tracer 
dose of Ca was taken orally and washed down with 200 ml of distilled 
water. Blood samples were taken at fifteen, thirty, sixty, ninety and 
one hundred and twenty minutes after the administration of the dose
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and the serum was counted in a Philips automatic liquid scintillation 
counter by the method described by Oxby and Kirby (1963). The purpose 
of using the small dose of calcium chloride was to avoid passive 
diffusion of calcium across the upper gastro-intestinal tract which 
might have occurred using larger doses. The distilled water was given 
in order to wash the calcium through the pylorus into the duodenum 
as soon as possible after the dose was given. Radiographic screening 
showed that most of the fluid in fact reached the duodenum within 
minutes of being taken. Carrier doses of 20 mg and 50 mg of calcium 
were tried and the method using 20 mg doses was found to be reasonably 
reproduceable and to correlate well with balance data (Wilkinson, 
1971a). The serum counts were expressed as the percentage of the 
administered dose and a curve could be constructed showing a rising 
number of counts over the first one and a half hours with a gradual 
fall-off thereafter. Analysis of the curve permitted the calculation 
of the fraction of the dose that was absorbed in the first hour, and 
this was termed the a-, value, the range in healthy adults being 
established as 0.35 - 0.90. 
Metabolic balance studies
Each calcium balance study took two weeks to perform. The first 
week was the equilibration period and the second the balance proper. 
In order to improve the sensitivity of the technique the use of 
various non-absorbable faecal markers was investigated by Wilkinson 
(1971b), and polyethylene glycol 4000 (Peg) was found to be most 
suitable. This enabled the technique of daily balances to be evolved, 
using endogenous creatinine as a urine marker. Thus the patient 
was given 500 mg of Peg three times a day with each meal during the
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equilibration and study weeks. Analysis of the faeces with correction 
according to the amount of Peg present enabled the daily estimation 
of absorption to be made. Similarly, by correction of the urine 
results to the average 24 hour creatinine output obtained during the 
whole week, the problem of the minor errors in urine calcium estimation 
due to the incomplete bladder emptying at the start or finish of the 
daily balance was overcome. The sum of the corrected amounts of daily 
calcium in the urine for the weekly period was not significantly 
different from the sum of the actual amounts excreted during the same 
time. Calcium and phosphorus were estimated in duplicate in a 
homogenized sample of the diet and on all faecal and urine samples, 
using ashed aliquots of faecal and diet homogenates taken up in 
hydrochloric acid and acidified samples of urine, the estimations 
being performed by the methods already described. The Peg content of 
the faeces was determined by the turbidimetric method of Malawer and 
Powell (1967). The advantage of this method of carrying out the 
calcium balance was that seven separate results could be obtained for 
each study and the mean calculated with its standard error.
Urine total hydroxyproline was measured on the urine collection, 
in order to complement the bone resorption rates calculated from the 
balance and isotopic bone formation rate studies. Since dietary 
gelatin would contribute to urine OHP, care was taken to ensure that 
the diets were gelatin free (Sjoerdsman et al. 1965) 
Bone x-ray measurements
For the purposes of this study, two forms of x-ray measurement 
were investigated, both using the second metacarpal. The first of 
these, the ratio of the cross sectional area of cortical bone to the
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total cross section area (Nordin & Smith, 1965) is a morphological 
measurement. The second, the estimated bone density of the cortex, 
is a photodensitometric method. A posteroanterior radiograph of 
the left hand was taken, the radiographic factors being FFD, 40"; 
current, 55 m. amps; time, 0.04 sees.; voltage, 52 kV; film type, 
Kodak Non-screen Auto-process. Processing was carried out by the 
Cronex auto-process for 3^ minutes. The x-ray was developed and 
the midpoint of the shaft of the bone located.
The total width of the bone at its mid-shaft position and the 
medullary width at the same site were each measured twice by one 
observer. The measurements were performed using needle-tipped 
Vernier calipers. From duplicate observations the experimental errors 
were evaluated and were found to be 0.010 cm for the total width and 
0.015 cm for the medullary width, this larger error being attributed 
to the comparative irregularity of the endosteal margins. The purpose 
of the measurement is to obtain an index of the amount of cortical 
bone present and this index has been expressed as the ratio of the 
cortical cross-sectional area of the bone at that point, assuming the 
metacarpal mid-shaft to have a cylindrical configuration. The 
validity of this measurement has been fully investigated by Horsman 
and Kirby (1972) who carried out morphological measurements of 50 
metacarpals and compared the results with the radiological values. 
The ratio of the cortical to the total cross-sectional area is 
calculated as follows:
CA/TA = 1 - (1-C/T) 2
where C is cortical width
and T is total width
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Attempts were also made to evaluate the metacarpal cortical density 
at the mid-shaft using a densitometer. The method was an extension 
of that described by Anderson et al. (1966) and the exact procedure 
has been given in detail by Horsman (1971). It is indirect and the 
accuracy of the resulting value is open to doubt, but for purposes 
of comparison the technique might be expected to be of some value. 
In practice, however, the normal range was extremely wide and the 
measurement was subject to a relatively larger error. This probably 
occurred because of the assumption of a cylindrical model for the 
metacarpal. The bone may be roughly oval or triangular in cross- 
sectional area so that the x-ray is passing through unpredictable 
quantities of bone. This will not greatly influence the simple 
linear measurements on which the CA/TA depend, but it is likely to 
affect the x-ray absorption to a considerable degree. A bone of oval 
section viewed in its major axis will obviously appear radiographically 
denser than one with a circular section but whose cortex is otherwise 
identical. Moreover, the question arises as to what is implied by 
the term metacarpal cortical density. Under ideal conditions and using 
the techniques and assumptions as described, the metacarpal cortical 
density could be reduced by a decrease in the true mineralisation of 
the bone, or alternatively by a widening of the Haversian canals. 
In practice it is extremely unlikely that the former type of change 
occurs even in severe osteomalacia, although there may be some small 
amount of osteoid deposition at the surface of the Haversian canals. 
Any change in density is probably caused by the latter process. Bearing 
in mind these inherent disadvantages both in the measurement and the 
concept of the metacarpal cortical density, the measurement was tested
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in 44 patients with varying degrees of chronic renal failure. No 
correlation could be found with any other parameter, in contrast 
to the CA/TA ratio which proved a useful measurement. The metacarpal 
cortical density was therefore abandoned in this study. 
Iliac crest biopsies
Using full aseptic technique bone biopsies were taken under 
local anaesthetic from the anterior iliac crest, approximately 3 cm 
behind the anterior superior spine. The periosteal surface was 
exposed, scraped down to bone with a periosteal elevator and a 
cylindrical biopsy core removed with a 5 mm trephine. The deep 
fascia was closed over the biopsy site with interrupted cat-gut and 
the skin was then re-sutured in a separate layer. A moderate sized 
haematoma occurred in one patient, but otherwise there were no compli- 
cations. Patients with malacic bone appeared to find the procedure 
more painful than those whose bone was normally mineralised. 
Quantitative bone histology
The bone sample was placed in neutral 10% formal-saline for twenty 
four hours and dehydrated by passing through graded alcohols, finally 
being transferred to absolute alcohol for twelve hours,
The most satisfactory process of embedding the bone involved 
steeping the fixed samples for three weeks in methyl-butyl metha- 
crylate monomer preparation, which included the polymerising agent. 
The mixture was made up of nine parts methyl methacrylate and one 
part butyl methacrylate, with 1 G benzoyl peroxide per 100 ml of 
monomer. This was normally stored over anhydrous copper sulphate at 
4°C. The specimens placed in this mixture were also kept at 4 C 
to allow maximum penetration without polymerisation occurring, using
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small glass jars with air-tight caps to prevent evaporation. After 
three weeks the jars were left at room temperature to allow polymeri- 
sation to occur, which generally took three to seven days. The butyl 
methacrylate component gave a slight plastic quality to the polymer 
which made sections less brittle and more suitable for sectioning.
After polymerisation was complete the jar was broken and the 
sample removed. The surplus polymer was trimmed off with a saw and 
the embedded specimen mounted horizontally on a 5 mm thick alloy plate, 
using Araldite.
Forty eight serial sections, approximately 12 y thickness, were 
cut using a Jung heavy sledge microtome with a K2 blade. Every third 
section was selected for staining with Toluidine Blue, and an alterna- 
tive set of sections were made up and stained with Osteochrome.
Quantitative counting was carried out according to the principle 
of Frost (1967) using a Leitz microscope at a magnification of x 80 
with a five line grid in the eye-piece.
Where possible, the thickness of the cortex of the iliac crest was 
measured by means of an eyepiece micrometer. A series of measurements 
approximately 100 y apart were taken and the mean value calculated. 
The method was unsatisfactory owing to the gradual transition from 
cortex to medulla.
It has been stated by Frost (1967) that mineralisation normally 
takes place in the part of the osteoid seam adjacent to the already 
mineralised bone. Initially, however, there are certain features of 
this newly formed bone which distinguish it from mature bone. In 
particular, lipid material appears to be present and Matrajt has shown 
that during normal mineralisation, this line of active calcification
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may be identified using a number of stains (Matrajt et al. 1967). 
When Toluidine Blue is used, a thin granular deep blue line shows 
up against the blue of mature bone and the turquoise of the osteoid. 
This zone has been designated the Mineralisation Front, and the fraction 
of osteoid seams with Mineralisation Fronts present may be estimated 
by grid counting. 
Clinical material
The patients in the study came from four sources. A relatively 
small group with frank osteomalacia was referred by urological surgeons 
for metabolic assessment. The majority of these patients had anatomical 
abnormalities of the urinary tract. Another group of patients came 
from a renal stone clinic although not all of these patients had renal 
stones. This clinic was supplemented by patients known to have chronic 
pyelonephritis, frequently referred by the urologists, and by patients 
with other forms of renal disease, who were seen initially as out 
patients or general medical admissions. The third source of patients 
was a nephrology clinic, where patients were referred for assessment 
of renal function and, when appropriate, consideration for long term 
dialysis. Finally, a small number of patients were gathered from 
another nephrology clinic, but the purpose of including this group was 
to widen the spectrum of biochemical abnormality, with special reference 
to the effect on bone histology.
Investigation of the patients generally followed a standard pattern. 
The patient was seen initially as an out patient and routine biochemical 
and haematological screening tests carried out. The patient was then 
admitted and more detailed studies were undertaken, provided the 
patient's general condition was stable, taking the out patient results
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into account. Treatment, where appropriate, was instituted following 
the investigations. Data from those patients who required urgent 
treatment, or whose metabolic state fluctuated, were not included in
the study. The patients were on no drugs which were likely to affect
drugs 
the results; only antibiotics, antihypertensive'or occasional small
doses of alkali were used. In no case were aluminium hydroxide, 
diuretics or anticonvulsants prescribed. Every attempt was made to 
ensure that metabolic measurements were made over a relatively short 
period of time, and the biochemical estimations were generally carried 
out on a single blood or urine sample collected in the fasting state. 
These biochemical tests were usually performed a few days after 
admission to hospital and generally seemed to be representative of 
the patient's metabolic state. It was noted when investigating 
biochemical relationships that tighter correlations emerged from 
data obtained from single samples than when the same comparisons were 
made using data that had been obtained a few days apart. All of the 
patients on whom iliac crest biopsies were carried out except one 
with renal tubular acidosis had sustained a blood urea level in excess 
of 100 mg/100 ml for at least a year. The majority of them had some 
degree of metabolic acidosis, but a small number who were closely 
observed had plasma bicarbonate levels persistently greater than 
20 mEq/L. Most of these patients had slowly progressive glomerulone- 
phritis and took alkali therapy. Another group of patients had 
bicarbonate levels which varied markedly around 20 mEq/L and these 
patients were therefore excluded from the study.
A diagnosis of pyelonephritis was made if at least three of the 
following criteria were fulfilled: a convincing history of recurrent
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urinary tract infections, repeated pyuria with a positive bacterial 
culture in mid-stream specimens of urine, radiological changes on 
intravenous pyelography (Edwards, 1965), histological evidence (Cotran, 
1965). Glomerular disease was diagnosed in most cases by percutaneous 
renal biopsy. The presence of polycystic disease was diagnosed radio- 
logically, supplemented by a positive family history in many cases. 
Miscellaneous forms of renal failure were diagnosed by appropriate 
techniques.
CHAPTER 5
Results
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SECTION 1
Cases of Florid Renal Osteomalacia
Eleven patients are described, representing the total number 
of cases with proven clinical osteomalacia with renal failure seen 
during the period of study. An outstanding feature of the study 
was severe metabolic acidosis. Five other patients were seen with a 
comparable degree of acidosis and in only one of these was osteomalacia 
excluded by thorough investigation. The other four presented some 
features of osteomalacia but were not included owing to the incomplete- 
ness of the data. 
Clinical material
Details of the eleven cases are shown in Table 2. They comprise 
six women aged 16 to 65, two men aged 54 and 61 and three boys aged 
4, 8 and 18. All except three had unequivocal evidence of chronic 
pyelonephritis with chronic pyuria and infection and radiological 
changes. Case GP had bilateral hypoplastic kidneys. No evidence of 
pyelonephritis was found in case RD but his underlying lesion was a 
congenital urethral obstruction, corrected at the age 2. Case HC 
gave a history of acute glomerulonephritis at the age 27, and had 
been asymptomatic until his presentation with muscle weakness and 
skeletal pain at the age 61. 
Presentation and bone status
Case RD, the 4 year old boy with uretero-vesical obstruction, 
and case GP, a 16 year old girl with bilateral small kidneys, probably 
resulting from pyelonephritis or obstruction in childhood (Hodson, 1967),
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both presented with genu valgum. Case GP also had a marked hip- 
girdle myopathy and an extensive Looser zone transversing most of 
the cortex of the left lower femoral shaft. Case HBr, an 8 year old 
boy with ureterostomy carried out for bladder neck obstruction and 
case LSI, a 60 year old woman with an asymptomatic stag-horn calculus 
and bilaterally scarred kidneys presented with spontaneous fractures 
of the tibia and femoral neck respectively. Hip-girdle weakness and 
bone pain were the major symptoms in cases PM, HC, HBa and IP. Case PM 
was an 18 year old boy who had had a bladder neck resection when 2 years 
of age, following investigation of polyuria. Some degree of incontinence 
persisted and a uretero-colic anastomosis was carried out at the age 7. 
Nine years later an ileal conduit was constructed, and at this time the 
patient reported that he was no longer able to run and had difficulty 
descending stairs. Case HC, a 61 year old man probably suffered an 
episode of acute glomerulonephritis with incomplete resolution. Case 
HBa gave a 20 year history of intermittent acute urinary tract infections, 
and was found to have evidence of active infection when she presented 
aged 61 with an obvious myopathy. Case IP, had a uretero-sigmoidostomy 
performed at the age of 45 along with excision of a carcinomatous bladder. 
She received intermittent courses of Vitamin D in therapeutic doses after 
hypocalcaemia was noted, but inspite of this, bone pain led to the 
discovery of Looser zones in both femora, confirming the diagnosis of 
osteomalacia.
Case MS had a uretero-colic anastomosis performed at the age of 43 
following unsuccessful local resection of a bladder carcinoma. Eleven 
years later when uraemic symptoms developed he was referred for general 
assessment. Case LSy had bladder neck obstruction from birth, in
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assocation with occult spina bifida, although the diagnosis was not 
made until age 7, when the patient was investigated for incontinence. 
A uretero-colic anastomosis was constructed, but this was converted 
to an ileal bladder at the age 15. Following this she was referred 
for assessment. Case WB originally presented aged45, with general 
ill-health and haematuria. A diagnosis of tuberculous pyelonephritis 
with extensive bladder involvement was established, and after treatment, 
the scarred bladder was enlarged with a segment of colon. The patient 
was referred for assessment aged 50. The renal function in cases RD, 
HBr, LSy, LSI and HBa appeared to be reasonably stable, but both cases 
HBr (an 8 year old boy) and LSI (a 60 year old woman) died from cerebro- 
vascular haemorrhage in association with hypertension. The remaining 
patients showed a slow but steady decline in renal function down to 
terminal levels over a tv/o to four year period of follow-up after 
their final presentation.
Radiographs of the bones showed fractures or pseudo-fractures 
and/or rachitic changes in every case except MS in whom the diagnosis 
of osteomalacia was confirmed by the reduced ash content (47%) of an 
iliac crest biopsy specimen (Morgan et al. 1968). Spinal density by 
visual inspection was obviously increased in eight of the cases. In 
all cases the metacarpal and femoral cortices tended to be thin, but 
frank periosteal resorption of bone was not seen. 
Results
The blood urea levels ranged from 72 to 327 mg/100 ml. All the 
patients had a substantial metabolic acidosis (bicarbonate below 
20 mEq/L) and there was hyperchloraemia in all but three cases (GP, MS, 
HC) with the most severe renal failure. Arterial blood pH values ranged
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from 7.24 to 7.32. All the patients but one (RD) had hypocalcaemia 
(serum calcium below 9.0 mg/100 ml). The plasma phosphate levels 
were variable (2.8 to 6.9 mg/100 ml). All the plasma alkaline phos- 
phatase values were high though in cases HBr and GP they were within 
the normal range, which in growing children is extremely wide (Sereny & 
McLaughlin, 1970). The serum calcium x phosphorus products ranged 
from 25 to 50.
Creatinine clearances were all below 20 ml/min. Twenty-four hour 
urine calcium was low in all cases (9 to 57 mg/24 hours), but when 
fasting calcium excretion was expressed in mg/100 ml of glomerular 
filtrate, it was raised - that is, over 0.14 - in all cases. Phosphate 
excretion expressed in mg/100 ml of glomerular filtrate was very high 
relative to the serum phosphate level in all cases indicating a reduced 
tubular reabsorption of phosphate. When the values are expressed as the 
maximum tubular reabsorption of phosphate, TmP, it is seen that all but 
one are below the normal range of 2.3 to 4.2 mg/100 ml (Bijvoet, 1969). 
Only two patients could achieve a urine pH below 5.8, despite the severe 
metabolic acidosis. Of these two, one had glomerulonephritis, in which 
the acidosis arises as a result of a diminished nephron population, and 
rarely runs the chronic course that occurred in this case. The other 
patient had a bicarbonate-losing state, which is an uncommon form of 
renal tubular acidosis (see Appendix: Case III). 
Comment
The striking feature of this series is the metabolic acidosis, 
which characterised all the cases. The fact that this acidosis is 
associated with impairment of urinary acidification in all but one 
case implies that most patients had a tubular defect, which would have
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led to a state of acidosis at a relatively early stage in the 
development of the renal disease. In the single patient with chronic 
glomerulonephritis, it is impossible to know the length of time for 
which acidosis had been present, but the overall history was 34 years. 
Of five other cases, not included here, but with a similar degree of 
acidosis, four probably had osteomalacia.
The series provides a further example of the close association 
that has been noted previously between renal acidosis and osteomalacia. 
The fact that renal osteomalacia was never seen in the absence of a 
severe metabolic acidosis adds emphasis to the association, and though 
it obviously does not necessarily indicate a causal relationship, it 
does seem to provide circumstantial evidence of one.
In view of these findings, it was appropriate to examine a group of 
patients with chronic renal failure of varying degrees, selected only 
on the basis of a raised plasma creatinina, in an attempt to evaluate 
the role of various biochemical abnormalities, in particular acidosis, 
in the bone disease of chronic renal failure.
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SECTION II
Identification of the Presence of Bone Disease
In order to establish what factors influence bone disease in 
chronic renal failure a group of fifty uraemic patients (none of whom 
was on dialysis) has been examined. Details of the fifty patients, 
all of whom had a plasma creatinine of over 1.6 mg/100 ml, are given 
in Tables 3 and 4. All the patients were known to be in a relatively 
stable state of chronic renal failure except for one, ES, whose condition 
had deteriorated clinically shortly before the investigations were 
carried out.
It seemed necessary to determine some parameter that would serve 
as a useful indicator of bone disease. An elevated plasma alkaline 
phosphate level is generally accepted as characteristic of active 
osteomalacia or rickets in spite of the fact that practically nothing 
is known about its role. Familiarity with the enzyme associated with 
this complete lack of understanding of its function has led to its 
acceptance as a virtually non-specific marker of certain types of 
disease, but is hard to believe that it will not eventually prove to 
be of major importance in calcium metabolism. It was therefore decided 
to see whether the alkaline phosphatase levels of the patients could 
be used as a criterion of their bone status.
Standard radiographs of the hand were carried out in forty four 
cases and the CA/TA ratio was calculated from the caliper measurements 
on the second metacarpal as described by Nordin and Smith (1965). When 
the CA/TA and the plasma alkaline phosphatase are compared there is a
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Fig- 5. Distribution of plasma alkaline phosphatase in 
patients with chronic renal failure, plotted arithmetically 
and logarithmically.
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significant inverse correlation (r = -0.38, p < 0.01). However, 
when the distribution of the alkaline phosphatase level is examined 
it is apparent that there is a very marked positive skew which can 
be partly normalised by using a logarithmic scale (figure 5). It 
therefore seems appropriate to consider the logarithm of alkaline 
phosphatase for purposes of comparison with other biological parameters. 
When this is done a significant inverse correlation persists between 
CA/TA and logarithm of alkaline phosphatase, but the r value becomes 
r = -0.50 (Table 5).
The normal ranges for both alkaline phosphatase and bone x-ray 
measurements vary with age and when this is taken into account the 
association between a reduced CA/TA (more than 1 standard deviation 
below the mean for the age) and a raised alkaline phosphatase is highly 
significant (p < 0.001). Thus a raised plasma alkaline phosphatase 
is generally associated with a reduction in the metacarpal cortical 
thickness and it may therefore be justifiably used to indicate the 
presence of bone disease without necessarily making any assumption as 
to the exact type. This being the case, it becomes possible to divide 
the patients into two groups according to the alkaline phosphatase, 
and the data of patients with normal alkaline phosphatase levels are 
shown in Table 3, and the data for the remaining patients are shown in 
Table 4.
Results
Plasma alkaline phosphatase and plasma calcium
Plasma calcium ranged from 5.3 to 10.7 mg/100 ml and was not
Using a rank correlation procedure for non-normal distributions 
r = 0.51.
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significantly related to the degree of renal failure as judged by the 
plasma creatinine concentration (figure 6). There is a highly signifi- 
cant inverse correlation between the logarithm of plasma alkaline 
phosphatase and plasma calcium (p < 0.005; figure 7; Table 5). 
Patients RD, HBr and SC whose ages were 4, 8 and 16 years respectively, 
have not been included since their plasma alkaline phosphatase levels 
were probably normal for their age, although ouside the normal range 
for adults. Patient ES, whose clinical condition had deteriorated 
shortly before the results were obtained, shows an inappropriately low 
plasma calcium for her alkaline phosphatase level, as judged by the 
remainder of the data.
In spite of the overall correlation between plasma alkaline phos- 
phatase and plasma calcium, six of the nineteen cases with a raised 
alkaline phosphatase had a plasma calcium that was definitely normal. 
Plasma alkaline phosphatase and plasma bicarbonate
There is an inverse correlation of doubtful significance between 
the logarithm of plasma alkaline phosphatase and the plasma bicarbonate 
(p * 0.05; figure 8; Table 5). Only one patient, JD, had a raised 
plasma alkaline phosphatase in the definite absence of acidosis. This 
man was suffering from retroperitoneal fibrosis, a condition which has 
certain systemic features, and it is possible that the excess alkaline 
phosphatase was derived from sources other than bone. However, enzyme 
studies to clarify this point were not performed, and there are no 
definite grounds to exclude his results. 
Comment
The plasma alkaline phosphatase level correlates significantly 
both with the degree of hypocalcaemia and the degree of acidosis.
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However, a raised alkaline phosphatase value may occur in the presence 
of normocalcaemia, which means that the hypocalcaemia cannot be an 
important cause of the raised alkaline phosphatase, though the bone 
state which is associated with raised alkaline phosphatase levels 
could be contributing to the hypocalcaemia. As far as the relation 
between alkaline phosphatase and the bicarbonate level is concerned, 
the pattern of the distribution of the data is irregular. Nevertheless, 
when the normal physiological ranges for the parameters are taken into 
account it can be seen that while acidosis need not necessarily be 
associated with a raised alkaline phosphatase, raised levels virtually 
never occur in the absence of an acidosis (figure 8). 
Bone X-ray measurements
The bone x-ray measurement used in this study was the ratio of 
the cortical to the total area of a cross-section of the mid-point of 
the second metacarpal (CA/TA). The normal value varies a small amount 
with age, and tends to be slightly greater in premenopausal women and 
slightly less in postmenopausal women than in men of the same age. 
In both sexes, the mean normal value at any age has a relatively large 
standard deviation.
The CA/TA value in the patients should therefore properly be 
considered in relation to age and sex, and it is possible to do this 
in at least two ways. The data may be expressed numerically as the 
difference from the mean value for the age and sex. Alternatively, 
since most of the points are scattered around one standard deviation 
below the mean (figure 9), they may be separated into two populations, 
depending on whether they fall above or below this value. Both modes 
of expression had disadvantages. In the first case, the difference
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from the mean being small, the relative error of the resulting value 
is large; in the second case, the choice of one standard deviation 
below the mean to split the data is entirely arbitrary, though the 
problem of errors is reduced.
Results
Bone X-ray measurements and plasma calcium
The CA/TA ratio varied from 0.39 to 0.80 in the males, and from 
0.33 to 0.85 in the females. The individual values with the mean and 
one standard deviation for the age and sex of the patient are shown 
in figure 9 and Table 6. There is a significant correlation when plasma 
calcium is related to the simple CA/TA ratio (p < 0.01; figure 10; 
Table 5) and a highly significant negative correlation is found when 
the comparison is made between the plasma calcium and the difference 
from the mean, (p < 0.001; Table 5). A highly significant association 
also exists between the plasma calcium concentration and the CA/TA 
ratio when the value of this is considered as greater or less than 
one standard deviation below the mean (t = 3.19, p < 0.001; figure 11). 
Bone X-ray measurements and plasma bicarbonate
When the plasma bicarbonate is related to the CA/TA ratio considered 
in these three ways, a moderately significant association is found 
with the simple CA/TA value (p = 0.05, figure 12), and its difference 
from the mean (p < 0.05; Table 5). However, no significant difference 
is found between the plasma bicarbonate levels of groups of patients 
whose CA/TA values are either greater or less than one standard devia- 
tion below the mean (t = 1.29, p = 0.10; figure 11).
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Metacarpal cortical width
The CA/TA ratio could decrease as a result of either endosteal 
resorption or periosteal accretion. However, when the metacarpal total 
widths in the normal alkaline phosphatase group are compared with the 
corresponding values in the raised alkaline phosphatase group, there 
is no significant difference (figure 13; Table 6). 
Comment
There are a number of difficulties in defining a group of bone 
x-ray values as normal or abnormal. The normal range, which varies 
with age and sex, is moreover so wide that an individual could undergo 
substantial bone loss as a result of a pathological process, and yet 
the CA/TA might remain within normal limits. For this reason, the 
CA/TA data have been considered in three ways: as absolute values; 
as the difference from the mean value for the age and sex of the patient; 
and according to whether they are greater or less than one standard 
deviation below the mean.
When any of these three modes of expression are used a significant 
positive association is found between the CA/TA value and the plasma 
calcium. There also appears to be some association between the amount 
of cortical bone and the plasma bicarbonate level, though the correlation 
is weaker than that seen with plasma calcium.
A low CA/TA value cannot be attributed to periosteal accretion and 
must therefore indicate endosteal resorption.
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SECTION III
Hypocalcaemia
Since the hypocalcaemia that commonly accompanies chronic renal 
failure is statistically related in these data both to a raised alkaline 
phosphatase level and a low metacarpal CA/TA value, it is important 
to test the possibility that acidosis might itself be influencing 
the plasma calcium level, if the relationships between acidosis, 
hypocalcaemia and bone disease are to be fully explored. The plasma 
calcium concentration is highly dependent upon renal tubular reabsorp- 
tion and consideration is given first to this aspect of calcium 
homeostasis.
Results
Plasma and urine calcium
No significant relation is found between plasma calcium and the 
degree of renal failure as judged by plasma creatinine (figure 6; 
Table 5).
Fasting calcium excretion can be expressed in two ways: as the 
calcium/creatinine ratio (Ca/Cr) which is a function of the absolute 
rate of excretion; and in mg/100 ml of glomerular filtrate (Car) 
which is excretion rate relative to GFR. The difference between these 
two modes of expression is illustrated in figure 14. Fasting Ca/Cr 
tends to be low in renal failure but may be within the normal range. 
Calcium excretion relative to GFR on the other hand is generally high. 
In both modes, calcium excretion tends to be high in the cases with 
raised alkaline phosphatase levels. Uhen calcium excretion relative 
to GFR is related to plasma creatinine (figure 15), it is seen to rise
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Fig. 16. Urine calcium excretion relative to GFR (CaE ) 
and fasting plasma calcium in patients with chronic renal 
failure. The lines indicate the normal relationship.
cs
1-5
1-0
0-5
0
o o
0 
•
° o
o 
o
o 
o
• o o
O O
8 o o»
oo
10 15 20 
Plasma Bicarbonate mEq/L
25
Fig. 17. The relation between Ca^ and plasma bicarbonate 
in patients with chronic renal failure.
11
o o
•OD
CO 
CJ
E
(A
0 
•
5L
0
0 ° o 
••
0
0 0
0
0
10 15 20 25 
Plasma Bicarbonate mEq/L
30
Fig. 18. The relation between plasma calcium and bicarbonate 
in patients with chronic renal failure.
_o
£ 7^
E
«/J
C9
a.
0
o o 
o
o 
o
00
00 o
0° ° O
O 9 
O O
4 8 12 
Plasma Phosphorus mg/100m!
16
Fig. 19. Plasma calcium and phosphate in patients with 
chronic renal failure. There is no significant relationship.
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with the degree of renal failure, though not sufficiently steeply to 
maintain a constant absolute rate of excretion in the face of declining 
renal function. Thus most of the points fall below the normal Ca/Cr 
limits as indicated in figure 15.
The relationship between fasting plasma calcium and calcium 
excretion per 100 ml of GF is shown in figure 16. The lines indicate 
the way in which urine calcium rises with the plasma calcium in normal 
subjects given calcium infusions (Nordin & Peacock, 1969). Values to 
the left of the normal range indicate reduced tubular reabsorption of 
calcium. There is a highly significant negative correlation between 
plasma calcium and calcium excretion relative to GFR (p < 0.001; 
Table 5), and cases with a raised plasma alkaline phosphatase tend 
to be those with the lowest plasma and highest urine calcium values, 
i.e. their tubular reabsorption of calcium is most severely reduced.
There is a highly significant inverse correlation between calcium 
excretion per 100 ml of GF and plasma bicarbonate (p < 0.001, figure 
17; Table 5) and the patients with a raised plasma alkaline phosphatase 
tend to be the most acidotic and the most hypocalcaemic (Table 7). 
There is also a significant correlation between plasma calcium and 
plasma bicarbonate when both groups are considered together (p < 0.01, 
figure 18; Table 5), but it should be noted that the plasma calcium 
is independent of the degree of acidosis among the patients with 
normal alkaline phosphatase levels. 
Plasma calcium and phosphate
The relation between plasma calcium and phosphate concentration 
is shown in figure 19. There is a weak inverse relation between these 
parameters which is not statistically significant (Table 5). Once
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again it is apparent that the cases with raised plasma alkaline phos- 
phatase tend to have hypocalcaemia, but it is clear that this hypo- 
calcaemia cannot be directly attributed to hyperphosphataemia since 
many of the corresponding plasma phosphate values fall within or 
only slightly above the normal range. 
Comment
There is a highly significant correlation between the calcium 
excretion relative to GFR and the degree of acidosis. It might be 
argued that acidosis could raise the urinary calcium excretion rate 
by increasing the proportion of plasma ultrafiltrable calcium. This 
is unlikely to be true. If the ultrafiltrable calcium were raised 
in this way while renal tubular handling remained unchanged, after 
an initial period of adjustment during which there would be a transi­ 
tory rise in calcium excretion, both the plasma ultrafiltrable calcium 
and the urine calcium excretion rate would settle back to their 
previous levels. This would lead to a situation in which the total 
plasma calcium concentration was slightly reduced; but calcium excretion 
relative to GFR would be unaltered. These data show clearly that there 
is a raised urinary calcium excretion per unit GF. The hypocalcaemia, 
where present, cannot be attributed to any reduction in plasma proteins 
(Table 5), and the data in Table 8 indicate that no such reduction 
is present.
It is therefore apparent that hypocalcaemia is associated with 
a reduced tubular reabsorption of calcium in these cases, and is 
presumably secondary to it. A renal tubular leak, however small, 
will always lower the plasma concentration provided that the rate of 
input, and therefore output, remains constant. In these data obtained
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from fasting subjects, the absolute excretion rate is frequently 
lower than normal (figure 14) and this will tend further to reduce 
the plasma calcium concentration, especially in cases with advanced 
renal failure.
It is of interest that patients with normal alkaline phosphatase levels 
appear to be protected in some way against the hypocalcaemia, which in 
the raised alkaline phosphatase group is associated with the metabolic 
acidosis (figure 18). 
Plasma and urine phosphate
The relation between plasma creatinine and plasma phosphate is 
shown in figure 20. There is a highly significant positive correlation 
between these parameters (p < 0.001; figure 20; Table 5), plasma 
phosphate appearing to rise continuously as renal function declines.
Absolute fasting phosphate excretion (the ratio of phosphate to
or even raised 
creatinine in the urine) is clearly maintained at a normal/level despite
renal failure, as shown in figure 21. It follows that phosphate excretion 
relative to GFR (P£ ) is always raised. Thus, urine phosphate differs in 
this respect from urine calcium (compare figures 14 and 21).
The relation between phosphate excretion per 100 ml of GF and plasma 
creatinine is shown in figure 22. This again shows that fasting phos­ 
phate excretion is maintained at a relatively constant level within 
the normal range at all degrees of renal failure and phosphate excretion 
relative to GFR therefore rises as GFR falls.
The relation between phosphate excretion relative to GFR and plasma 
phosphate is shown in figure 23. The overall correlation is highly 
significant (p < 0.001; figure 23; Table 5). The normal relationship 
between these parameters is indicated and corresponds approximately to
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the normal splay defined by Bijvoet (1969). Since virtually all the 
PE values are over 1 mg/100 ml of GF it can be assumed that tubular 
reabsorption of phosphate is maximal, and the position of the points 
relative to the TmP lines therefore indicate the maximal reabsorptive 
capacity, this normally being about 3 mg/100 ml of GF (Bijvoet, 1969). 
It is clear that the TmP is reduced in nearly every case (Tables 3 and 
4). There is no significant correlation between TmP and plasma 
calcium or bicarbonate (Table 5). 
Comment
These data show that plasma phosphate rises in proportion to the 
degree of renal failure but the kidney clears normal quantities of 
phosphate in absolute terms, meaning that the tubular reabsorption of 
phosphate falls as renal function declines. There is much evidence 
that this effect is due to parathyroid activity (Slatapolsky et al. 
1968), and the reduction in tubular reabsorption i;i these cases is 
interpreted as indicating secondary hyperparathyroidism.
1-0
0-5
o 
en
O o
o
G
•
o o
10 20 30 
Plasma Greatinine mg/100m!
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absorbed per hour) at varying degrees of renal failure. 
The lower limit for normal absorption is shown.
1-0
°'5
0 
CO
10
8
° 
•
o 
o
8
15 20 
Piasma Bicarbonate mEq/L
o 8
25
Fig. 25. The relation between calcium absorption (fraction 
of tracer dose absorbed per hour) and plasma bicarbonate 
in patients with chronic renal failure.
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SECTION IV
Calcium Absorption
The malabsorption of calcium which accompanies chronic renal 
failure is often thought to be of importance in the pathogenesis 
of the bone disease. The logic behind this assumption is open to 
doubt as Stanbury (1968a)has pointed out, but it is conventional 
to consider absorption in any discussion of renal bone disease, 
and accordingly some consideration is given here to this aspect of 
calcium metabolism. The results presented are of some relevance 
to the final conclusions.
Absorption has been studied in the basal state by means of a 
standard test using radio-calcium, and on a daily basis by means of 
a modified version of the conventional metabolic balance technique.
Results
Calcium absorption test.
The relation between radio-calcium absorption and plasma creatinine 
is shown in figure 24. The fractional radio-calcium absorption is 
reduced below the lower limit of normal of 0.4 per hour in most of 
the cases, regardless of the degree of renal failure, the lowest 
absorption values being seen in the cases with a raised alkaline 
phosphatase. When the fractional absorption is related to the plasma 
bicarbonate, a highly significant correlation is found (p < 0.005; 
figure 25; Table 5).
The relative contribution of the degree of renal failure (i.e.
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Fig. 26. Calcium absorption (fraction of tracer dose 
absorbed per hour) and plasma calcium in patients with 
chronic renal failure. The lower limit for normal 
absorption is shown.
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plasma creatinine) and the degree of acidosis (i.e. plasma bicarbonate) 
to malabsorption of calcium was tested by the technique of multiple 
regression analysis. This shows that when the significant effect of 
acidosis on calcium absorption is allowed for, there is no further 
contribution from the degree of renal failure.
QI = 0.0259 - 0.0063 Cr* + 0.0156 HC03**
*N.S. 
**p < 0.01
The relation between calcium absorption and plasma calcium is shown in 
figure 26. The patients with the highest absorption values were normo- 
calcaemic whereas all the hypocalcaemic cases had malabsorption. There 
is however a group of cases with normocalcaemia and malabsorption. 
Metabolic balance studies.
Balance studies were carried out in seventeen patients, whose 
plasma creatinine levels ranged from 1.7 to 19.0 mg/100 ml. These 
patients were in a state of chronic renal failure and were not at the 
time of the study receiving treatment, other than small quantities of 
alkali, given as sodium bicarbonate, where necessary. A daily balance 
technique was used and the results are shov/n as the mean of a seven 
day period. Most of the patients were in essentially zero balance 
but four were in negative balance of mo/ han -2.5 rv'Kg b.w./day 
and one, a case of severe osteomalacia with a myopathy, v/as in a positive 
balance of 4.7 nig/Kg b.w./day (figure 27).
No significant difference was found in either the plasma calcium 
level or degree of acidosis between the patients with or without a 
negative balance (Table 9). There was no indication that the dietary
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calcium affected the balance state although the effect of very high 
calcium intakes was not examined. A low calcium intake was not 
necessarily associated with a negative balance state (figure 27).
A positive correlation exists between faecal calcium and phosphorus 
intake, but patients with a negative calcium balance were not those 
with a particularly high dietary phosphate (figure 28).
In order to test directly the effect of the acidosis on the balance 
state, in six cases two consequetive studies were carried out, each with 
one week's equilibration. After a loading dose of sodium bicarbonate, 
alkali (75-90 mEq/day) as sodium and potassium bicarbonate was administered 
during the second study, the blood pH rising in all cases and reaching 
a normal value in five patients. This correction of the metabolic acidosis 
was accompanied by a rise in net calcium absorption in all cases (paired 
t = 2.58, p < 0.05) and a simultaneous fall in urine calcium excretion 
(paired t = 3.80, p < 0.02) in all but two in whom it remained unchanged 
so that overall calcium balance became more positive (paired t = 3.27, 
p < 0.05; figure 29). There was no definite rise in the plasma calcium 
during the period of observation, and the creatinine clearance values 
remained almost constant (Table 10). 
Comment.
These results suggest acidosis, rather than simply the degree of 
renal failure, is an important contributing factor in malabsorption of 
calcium that accompanies uraemia. Both plasma creatinine and a reduction 
in plasma bicarbonate appeared to influence calcium absorption adversely 
as judged by the radio-calcium absorption test, but multiple regression 
analysis implies that acidosis is the predominant factor.
In the balance studies there was no evidence that the degree of
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renal failure, plasma bicarbonate or the diet itself influenced the 
balance state when the results were considered as a group. However, 
when the acidosis was corrected in five patients calcium absorption 
improved in every case, indicating clearly the importance of acid-base 
status in this respect.
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SECTION V
Bone Kinetics
There is very little available information on bone kinetics in 
chronic renal failure and although it is generally assumed that bone 
resorption is increased in some patients, no attempt has been made 
to quantitate this increased resorption or to assess its frequency. 
Moreover since most patients in chronic renal failure are in approxi­ 
mately zero calcium balance, it follows that when the resorption rate 
is raised the formation rate must also be elevated. It is therefore 
of relevance to examine the bone mineralisation rate and in the 
present study turnover measurements were made in 17 patients, with 
metabolic balance studies being carried out during the same period. 
The formation rate was calculated from the rate of disappearance of 
radio-calcium into the skeleton, and resorption was determined indirectly 
from the difference betv/een the mineralisation rate and the balance. 
Urine total hydroxyproline was also estimated as an independent measure 
of bone breakdown. 
Bone turn-over rate.
It is clear that mineralisation rates are generally raised, especially 
in patients with raised plasma alkaline phosphatase levels (figure 30; 
Table 11). Only one such patient had a mineralisation rate within the 
normal range. Resorption rates were also raised in most cases and 
this is again a feature of those patients with raised alkaline phos­ 
phatase levels. When the urine hydroxyproline output is compared with 
the resorption rate, a highly significant correlation is found
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(p < 0.001, Table 5) supporting the validity of this indirect method 
of measurement.
In the six patients with a severe metabolic acidosis and moderately 
severe impairment of glomerular function (GFR 5-16 ml/min) on whom 
balance studies were carried out before and after administration of 
alkali, an attempt was made to see whether correction of the acidosis 
would alter the mineralisation rate. In five patients a normal blood 
pH was achieved but in the remaining patient the acidosis was only 
partially corrected. The results of the study are shown in figure 31 
and Table 12. The mineralisation rates increased in all five patients 
in whom the acidosis was corrected (expressed as a percentage of the 
control value, paired t = 2.85, p < 0.05) but appeared to fall slightly 
in the patient in whom correction was not achieved. The rise in minera­ 
lisation rate exceeded or was not significantly different from the 
positive shift in calcium balance (Table 13). These events were un- 
associated with any alteration in plasma calcium or alkaline phosphatase 
or with a change in creatinine clearance (Table 10). However, plasma 
phosphorus fell significantly with alkali (paired t = 3.76, p < 0.02) 
and this was reflected in a decreased urine phosphorus excretion (paired 
t = 6.47, p < 0.01). The maximal tubular reabsorption of phosphate, 
TmP, did not change significantly (paired t = 1.62, n.s.). The effect 
on bone resorption rate v/as unpredictable. It remained unchanged in 
four patients but rose in two in whom a large change in mineralisation 
rate took place. Urine hydroxyproline rose variably with alkali 
treatment, but again correlates closely with the calculated resorption 
rate (figure 32).
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Comment.
When the skeleton as a whole is considered, both bone mineralisation 
and bone resorption rates are frequently elevated in chronic renal 
failure and on occasions bone turnover is taking place at many times 
the normal rate.
Osteomalacia implies a sluggish rate of mineralisation at the bone 
surface but the apparently contradictory observation that these patients 
have a high bone formation rate can be explained when the total number 
of mineralising sites in the skeleton is considered, for these may be 
so many that the overall rate of calcium deposition is also increased 
(Frost, 1967). Normal bone turnover rates are occasionally seen, but 
rarely in patients with raised alkaline phosphatase levels. It is 
important to note that the indirectly calculated resorption rate 
correlates significantly with the urine hydroxyproline output which 
was used as an independent indicator of bone breakdown.
The results of the balance and bone turnover study before and after 
treatment with alkali extend the known effects of acidosis to include 
a direct action on skeletal metabolism. The positive trend in the 
balance with correction of the acidosis might have been reflected in 
an elevation of the plasma calcium concentration and the fact that 
this did not occur suggests that the calcium was cleared into some 
other pool. The rise in the mineralisation rate was sufficient to 
account for this retention of calcium in all cases (Table 13).
It may be objected that the estimated rise in mineralisation rate 
does not represent mineralisation at all, but is the result of 
deposition of alkaline calcium salts, such as calcium carbonate, in 
the tissues or skeleton. Certainly a moeity of calcium exists physio­ 
logically in this form (Pellegrino & Biltz, 1965) but simple precipitation
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is unlikely to be the explanation for at least two reasons. 
Precipitations of calcium salts with correction of the acidosis 
would take place fairly quickly and then cease, whereas the isotope 
studies show a continual removal of calcium by a steady process 
during the second week after this correction was achieved. Secondly, 
the amount of calcium precipitated in a given time would be a function 
of the change in pH, whereas the observed increase in mineralisation 
rate is an approximate function of the initial rate (figure 31). Also 
the observed fall in plasma phosphorus that occurred with alkali 
therapy, though open to several interpretations, is consistent with 
the idea that true mineralisation has taken place. The fall in urine 
phosphorus was presumably the result of the decreased plasma level, 
since tubular reabsorption remained unchanged. It therefore appears 
that the slowing of mineralisation at individual bone forming sites 
which leads eventually to histological osteomalacia is aggravated by 
metabolic acidosis, since correction of this leads to an increased 
mineralisation rate. Although there are probably many factors which 
contribute to the development of renal osteomalacia, the present study 
strongly suggests that acidosis is one of them. The bone resorption 
rate can only be measured indirectly but appeared to increase in the 
two patients whose mineralisation rates rose markedly, and was 
unchanged in the other cases. This variation in resorption rate 
cannot be explained from the data, but had resorption not risen in 
the two patients in whom the mineralisation rate exceeded the increase 
in calcium balance, then the plasma calcium would almost certainly 
have fallen.
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SECTION VI
Bone Histology
The enzyme alkaline phosphatase may be derived from a number 
of sources though when of bony origin its exact relationship with 
bone turnover is not clear. It is usually thought that bone alkaline 
phosphatase results from osteoblastic activity though histo-chemical 
evidence is hard to find. However, while it is true that the plasma 
alkaline phosphatase is known to be elevated in most states where 
excessive osteoid is present, as in the bone of the growing child 
or in osteomalacia, it is in precisely these states that a rapid rate 
of bone break-down also occurs. Furthermore, it is a well known 
clinical fact that in chronic renal failure complicated by osteitis 
fibrosa, where bone destruction is such a major feature, the alkaline 
phosphatase level':, are frequently very high indeed. In the present 
work, the concentration of the enzyme is used as a simple indication 
of the presence of bone pathology, and it is necessary to determine 
which facet of turnover - formation or resorption - the alkaline 
phosphatase level reflects.
Secondly, it is important to establish what connections exist 
between the acid-base status and the plasma calcium level of the 
individual, and the fraction of bone surface that is coated with 
osteoid or undergoing resorption.
Results.
Bone histology and plasma alkaline phosphatase
A raised plasma alkaline phosphatase appears to reflect the
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proportion of surface coated with osteoid (i.e. the degree of osteo­ 
malacia). This is shown in figure 33. The plasma alkaline phosphatase 
was raised in fourteen of the twenty-one cases, in all of whom the 
proportion of trabecular surfaces coated with osteoid was abnormally 
high (over 25%). The proportion of osteoid surfaces showing a normal 
calcification front was estimated in eight of the biopsies and was 
abnormally low (less than 50%) in all these cases, including one 
with a normal alkaline phosphatase (Table 14). While the percentage 
of osteoid coated surface is significantly related to the logarithm 
of the plasma alkaline phosphatase, (p < 0.001, Table 15) the per­ 
centage of surfaces undergoing resorption is not (figure 34). 
Osteoid and plasma calcium and plasma bicarbonate.
The fraction of trabecular surface covered by osteoid ranged from 
11-96 per cent. A highly significant inverse relationship exists 
between the fraction of surface undergoing formation and the plasma 
calcium concentration (p < 0.001; figure 35; Table 15), but in two 
patients, both with renal tubular acidosis, a particularly severe 
degree of osteomalacia was apparent in spite of a relatively normal 
plasma calcium. In none of the patients was hypophosphataemia a 
feature (Table 14). In four patients in whom the plasma calcium 
was definitely normal, osteomalacia was present as judged by a raised 
level of osteoid coated bone surface. All patients with hypocalcaemia 
had osteomalacia.
When the degree of osteomalacia is considered in relation to the 
prevailing plasma bicarbonate level, a highly significant inverse 
correlation is found (p < 0.001; figure 36; Table 15). Two patients 
had definite osteomalacia with a minor degree of metabolic acidosis, 
and of the five patients that were not acidotic only one had well 
established osteomalacia.
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When the percentage of osteoid surface is considered in relation 
to the plasma creatinine concentration, there is no correlation but the 
data split into two groups (figure 37). The patients in one group 
had severe osteomalacia with a fractional osteoid surface of at least 
70 percent while the remainder had osteomalacia of mild degree or none 
at all. The plasma bicarbonate level in the former group ranged from 
10-19 mEq/L, with a mean of 14.1 mEq/L. The corresponding range 
for plasma bicarbonate in the latter group was 13-25 mEq/L with a mean 
of 19.6 mEq/L. These differences are significant (p = 0.01). Similarly, 
when the relative influence of the degree of renal failure and of acidosis 
are considered with respect to the severity of the osteomalacia using 
multiple regression analysis, the significant relationship with acidosis 
persists, but the degree of renal failure does not contribute.
FQS == 128.01 - 1.25 Cr* - 3.82 HC03**
where F is percent surface covered by osteoid
* N.S. 
** p < 0.001
There is no significant relation between the plasma bicarbonate and
creatinine.
Comment.
This study clearly shows that a raised alkaline phosphatase level 
reflects the osteomalacic state and is not directly indicative of bone
resorption.
There is an overall correlation between the degree of osteomalacia 
and the presence of hypocalcaemia, though it is evident that osteomalacia, 
sometimes of severe degree, can exist with little or no abnormality of
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plasma calcium concentration.
A highly significant correlation exists between the percentage 
surface covered with osteoid and the degree of acidosis, although 
in one case osteomalacia is fairly marked in spite of a mild degree 
of acidosis and in another definite osteomalacia is present in the 
absence of acidosis. It may be argued that the osteomalacia is a 
consequence of co-existing uraemia and is unrelated to the metabolic 
acidosis. However, in these data there is no good association between 
the metabolic acidosis and the degree of renal failure as judged by 
the plasma creatinine concentration and it is clear that the presence 
of excessive amounts of osteoid is related to the acidosis rather 
than simply the degree of renal failure. 
Resorbed surface and plasma calcium and plasma bicarbonate.
When the percentage of total trabecular surface undergoing resorption 
is related to the plasma calcium concentration no correlation is found 
(figure 38; Table 15). There is an inverse relation between the per­ 
centage of available surface undergoing resorption and the plasma calcium 
concentration (p < 0.001; figure 39; Table 15). Similarly, when 
the fraction of total surface undergoing resorption is related to the 
degree of acidosis, no association is apparent (figure 40; Table 15), 
but when the percentage of surface available for resorption is considered 
a moderately significant negative correlation is found (p < 0.05; figure 
41; Table 15). 
Comment.
These data show that the overall rate of resorption taking place in 
trabecular bone is neither related to the degree of hypocalcaemia nor 
the degree of acidosis and it is, in the final analysis, this absolute
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rate of bone destruction that would determine the rapidity with which 
bone disease developed. On the other hand, there is a significant 
correlation between the degree of hypocalcaemia and the fraction of 
available surface undergoing resorption, although the scatter is very 
wide. If bone resorption is mediated by parathyroid hormone, these 
results are consistent with the concept of hypocalcaemia leading to 
increased parathyroid hormone secretion, which would, in turn, result 
in more active bone resorption at surfaces not covered by osteoid. 
There is clearly a great deal of variability in this process. With 
regard to the association between fraction of available surface under­ 
going resorption and the degree of metabolic acidosis, the 
significant relationship may simply reflect the correlation already 
noted between metabolic acidosis and hypocalcaemia, or alternatively, 
might be due to some other, more direct effect of metabolic acidosis 
on the resorbing process. 
The mineralised bone mass.
In chronic renal failure the bone resorbing process that is known 
to occur does not usually lead to a generalised osteoporosis, but cystic 
lesions or areas of sub-periosteal erosion may be seen radiologically. 
In a proportion of cases however certain bones, especially those of the 
vertebral column, actually look sclerotic. This can be due to large 
increases in non-mineralised osteoid, as Garner and Ball (1966) pointed 
out, or even to an increase in mineralised trabecular bone. The amount 
of mineralised tissue per unit volume of bone has therefore been estimated 
in the present series.
Results.
Of the twenty-one biopsies that were examined, the proportion of
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bone (including mineralised tissue, osteoid tissue and marrow space) 
that was occupied by mineralised material was measured. In only two 
cases did the mineralised fraction exceed the normal upper limit of 
30% but in eight others it was close to this value (> 26%). 
Comment.
The osteosclerosis of chronic renal failure has been discussed 
by Stanbury (1967) who states that the amount of mineralised cancellous 
bone is not usually increased, but when the frequently thick osteoid 
coating is taken into account, the radiological density is readily 
explained. The biopsies in the present series suggest that the 
trabecular bone is well mineralised as a rule, regardless of the 
osteoid covering, and occasionally the amount of mineralised tissue 
is substantially increased. In conjunction with the observations of 
Pellegrino and Biltz (1965) who noted increasing cortical porosity with 
time in chronic renal failure, these results imply that a shift of 
mineral from cortical to trabecular bone takes place in this situation. 
Cortical thickness of the iliac crest.
The structural strength of bone is in most situations dependent 
upon the cortical thickness and it therefore seemed necessary to examine 
this in the iliac crest specimens. This was possible in ten of the renal 
failure patients in whom the cortex was intact. For comparison, the 
cortical thickness was also measured in sixteen normal adults, aged 20 
to 50 years, and in four patients with primary hyperparathyroidism.
Results.
The cortical thickness varied from 0.02 to 2.13 mm in the controls, 
from 0.52 to 1.31 mm in the patients with primary hyperparathyroidism, 
and from 0.16 to 1.39 mm in the renal failure cases. There was no
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correlation with either the percentage bony tissue in the trabecular 
zone or the fractions of available surface undergoing resorption. 
Comment.
This apparent failure of the cortex of the iliac crest to serve 
as a useful parameter of the structural status of the skeleton may be 
due to a number of reasons. Firstly, it is possible that in some cases 
oblique sections were being obtained, giving false high readings. 
However, because of the method of obtaining the biopsy and embedding it, 
which automatically resulted in sections being taken at right angles to 
cortex, this seems unlikely. A second possible explanation is that the 
exact site for obtaining strictly comparable specimens from the iliac 
crest is critical, for when two biopsies were taken simultaneously 
about 1 cm apart, there often appeared on naked eye examination to be 
somewhat thicker cortical bone in the posterior sample. Finally, it 
is conceivable that the cortex of the iliac crest, never being subjected 
to large compressive forces, shows natural greater variability in its 
development than the cortices of cylindrical bones.
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SECTION VII
The Calcaemic Action of Vitamin D
The apparent resistance to Vitamin D in chronic renal failure 
is not fully understood but must be due in part to the disturbance 
of the intermediate metabolism of the vitamin (Mawer et al. 1973). 
The hypocalcaemia which is a feature of renal osteomalacia can be 
corrected if sufficiently large doses of Vitamin D are given, and 
this effect is usually ascribed to increased intestinal absorption 
and bone resorption in response to high concentrations of partially 
hydroxylated derivatives like 25-hydroxycholecalciferol (Brumbaugh & 
Haussler, 1974; Reynolds et al. 1974)
In this study absorption has been assessed by the radio-calcium 
test and some indication of the state of bone resorption can be 
inferred from the fasting urine calcium excretion, whose source is 
probably the skeleton.
Results.
The effect on the radio-calcium absorption test of oral Vitamin D 
given daily in varying amounts for six weeks is shown in figure 42. 
There is a clear upward trend in absorption with increasing dosage, 
though the effect of moderately small doses was not examined.
The effect of Vitamin D on fasting plasma and urine calcium in 
10 patients is shown (figure 43) and though in all but one the plasma 
calcium rose, the urine calcium remained unchanged or even declined. 
This means that tubular reabsorption has increased, but not necessarily 
that the renal threshold for calcium has changed.
10-0
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Plasma 
Calcium 
mg/1GOmi
50
Urine
Calcium
mg/day
25
-2 -1 0 
Time weeks
Fig. 44. The effect on plasma and urine calcium of 
Vitamin D 50,000 !.U. daily, given at time 0 to a 
patient with renal osteomalacia.
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Fig. 45. The effect of oral Vitamin D for six weeks on 
the relation between plasma and urine calcium established 
by calcium infusions in a patient with renal osteomalacia. 
The GFR was 8 ml/min at which level the Car- 3.0 mg/100 ml 
GF corresponds to an absolute urine calcium excretion of 
350 mg/24 h.
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In a number of patients with renal osteomalacia, the effect of 
treatment with pharmacological amounts of Vitamin D, the first dose 
being given by intra-muscular injection, was studied by examining 
plasma and urine calcium at intervals during therapy. The results 
for one such patient (Appendix: Case IV) are shown (figure 44). The 
complete disappearance from the urine of measurable amounts of calcium 
while the plasma level rose indicates a major change in renal tubular 
handling of calcium. The effect however was not maintained, for 
during the second week of therapy the urine calcium returned to its 
original value though a higher plasma calcium concentration was sustained. 
The onset of these effects was never observed within thirty hours of 
the initial dose of Vitamin D in careful observations on six patients.
In order to see whether a change in renal threshold occurred to 
account for the correction of hypocalcaemia with Vitamin D, in some 
patients calcium infusions were carried out before and after therapy. 
The results of one such study are shown (figure 45). It is clear that 
entry of calcium into the plasma from the infusion - though this might 
equally well have been from the gut or bone - resulted in an immediate 
elevation of both plasma and urine calcium. In order to sustain a 
normal plasma calcium level without Vitamin D treatment, in the steady 
state, calcium would have had to enter the plasma and leave in the 
urine at a rate equivalent to 350 mg/24 hours (Infusion 1). Correction 
of the hypocalcaemia with Vitamin D was not achieved in this way at all, 
but took place with very little change in urine calcium excretion by a 
marked shift in renal threshold (Infusion 2).
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Comment.
These observations indicate clearly that Vitamin D improves or 
corrects the reduced tubular reabsorption of calcium in renal hypo- 
calcaemia, and this largely or wholly accounts for the calcaemic 
action of the vitamin in this condition. The transient total dis­ 
appearance of calcium from the urine that occurred initially with 
therapy probably does not represent entirely a true trans-tubular 
reabsorption but may be due in part to uptake of calcium by intra- 
cellular organelles prior to the enhancement of trans-cellular movement 
(Borle, 1970).
Vitamin D also corrects the malabsorption of calcium but while this 
may make some contribution to plasma calcium homeostasis, it cannot be 
decisive factor since plasma calcium is raised without a corresponding 
elevation of urine calcium, and tubular reabsorption must therefore 
be the dominant factor. The results of the infusion study also emphasise 
the fundamental nature of the change in renal handling of calcium in 
response to Vitamin D.
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SECTION VIII
Acidosis and Experimental Rickets
The influence of acidosis on the healing of rickets induced 
experimentally in rats was tested in the following way. Male Wistar 
rats were raised by mothers fed a low Vitamin D diet. After weaning 
at twenty days, the animals were kept for a further four weeks on a 
modified Steenbock diet (Ca/P, 7:1) by which time rickets was well 
established. Twenty animals of similar weight (55-75 G) were then 
selected and divided randomly into two groups. Group C continued 
with the diet and distilled water while Group A received the diet but 
drank 0.15 M NHLCl. After one week, blood was taken from each animal 
by cardiac puncture under ether anaesthetic and plasma calcium, 
phosphorus, alkaline phosphatase and pH were measured. The hind limbs 
were then x-rayed. Following this, each animal received by subcutaneous 
injection 50 ng (125 picomole) of 25-hydroxycholecalciferol and after 
four and ten days further blood samples and x-rays were taken.
The x-rays were presented twice in random order to an independent 
experienced worker (Dr E. Kodicek) who assessed the severity of the 
rickets using the Bourdillon scale. 
Results.
The results are shown in Table 16 and figure 46. After one week on 
NH.C1 the Group C animals had a mean blood pH 7.35, and Group A animals 
had a mean blood pH 7.21, these differences being highly significant 
(p < 0.005). The Group C mean plasma calcium and phosphorus levels were
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10.4 mg/100 ml and 6.9 mg/100 ml respectively, and in Group A the 
respective values were 10.1 mg/100 ml and 6.5 mg/100 ml. The differences 
between the two groups are not significant. The plasma alkaline phospha- 
tase level was greater than 60 KA units/100 ml in all cases.
The mean values on the Bourdillon scale were 1.18 for Group C and 
0.50 for Group A, and these differences are not significant.
Four days after the 25-hydroxycholecalciferol there were already signs 
of healing, but the effect was more marked at ten days. At this time, 
the mean plasma calcium and phosphorus levels in Group C were 10.8 mg/ 
100 ml and 10.5 mg/100 ml respectively and in Group A were 10.5 mg/100 ml 
and 10.6 mg/100 ml respectively, the groups not being significantly 
different with regard to these parameters. However, when the x-ray values 
were obtained, healing of the rickets was significantly delayed in the 
acidotic animals (figure 46), the mean Bourdillon scores being 4.9 in 
Group C and 2.6 in Group A (p « 0.01; Table 16). 
Comment
The Vitamin D metabolite 25-hydroxycholecalciferol has been shown 
to have potent anti-rachitic activity in the rat (Omdahl et al. 197') 
and the present study confirms this. The animals were severely rachitic 
when the material was administered and both groups showed evidence of 
healing four days after a single small dose. However, partial inhibition 
of the healing process occurred in the acidotic animals, indicating that 
acidosis can interfere with normal bone formation and predispose to the 
rachitic state. This experimental model strongly suggests that the 
relationships already noted between acidosis and osteomalacia are 
cause and effect rather than simply independent consequences of renal 
disease.
CHAPTER 6
Discussion and General Summary
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Osteomalacia and Osteoclasis
The contribution of metabolic acidosis to bone disease in chronic 
renal failure remains controversial. It is clear that the vast majority 
of patients with overt bone disease are severely acidotic, and the 
various explanations for the association have inevitably helped to 
entrench, falsely or otherwise, the idea of a causal relationship. 
It is however the experience of many nephrologists that marked acidosis 
can be tolerated by some patients without the development of clinical 
bone disease. Furthermore, certain of the arguments used to explain 
the part played by acidosis in bone disease when it does occur can 
be dismissed as only qualitatively consistent with the clinical and 
biochemical evidence.
An additional difficulty arises from the fact that renal bone 
disease consists of two quite distinct components, osteomalacia and 
osteoclastic resorption. Neither process is fully understood, but 
in the former there is a breakdown in the orderly production of bone 
tissue with a slow but persistent deposition of osteoid and, in most 
cases, an even slower rate of mineralisation. The bone resorption 
component is usually regarded as being entirely parathyroid hormone 
mediated. These two elements commonly coexist, sometimes one or other 
predominating. Clinical osteomalacia takes years to develop, not 
surprisingly, since it involves a reduced rate of bone formation 
which is a slow process under normal circumstances. Severe parathyroid 
induced bone resorption on the other hand seems able to take place 
rapidly by comparison, sometimes appearing over months, and it may 
therefore exist either with little sign of osteomalacia or superimposed
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on osteomalacia of severe degree.
In general, bone fractures, whether partial (Looser zones) or 
complete are a feature of osteomalacia rather than osteitis fibrosa. 
This is probably due to the fact that in osteomalacia, where bone 
formation is defective, any break, however small, cannot heal but 
continues to weaken the adjacent structure with eventual extension 
of the fracture. When bone resorption predominates, these incomplete 
fractures are not seen though the areas of erosion and cyst formation 
must weaken the bone. This strongly suggests that healing can take 
place, and this may be due to the action of parathyroid hormone which 
is able to promote bone formation in certain circumstances (Talmage, 
1966; Parsons et al. 1973).
In osteomalacia, bone resorption is usually increased above normal 
levels, presumably as an indirect result of the hypocalcaemia, though 
the osteoid surface which coats the trabeculae is curiously resistant 
to resorption and protects the bone to some extent (Wolbach, 1947). 
It has also been suggested that parathyroid activity is only moderately 
increased in osteomalacia in spite of the prolonged hypocalcaemic 
stimulus (Stanbury, 1967; Ell is, 1973). The cause of this is not clear: 
it cannot be explained in terms of the plasma phosphate level which is 
usually lower in osteomalacia than in osteitis fibrosa (Stanbury & 
Lumb, 1966) since it has been shown that phosphate affects the para­ 
thyroids entirely by its action on ionised calcium (Reiss & Cantebury, 
1971). It may be that osteomalacia cannot persist in the presence of 
severe secondary hyperparathyroidism. 
Bone resorption.
In the present series the reduction in CA/TA ratio indicates an
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endosteal resorption process, since it is not due to periostea! 
accretion (figure 13). In an independent study using identical 
radiological techniques Hossain et al. (1970) showed that in primary 
hyperparathyroidism, the CA/TA ratio tended to be low for the age 
of the patient. It has also been shown that in chronic renal failure 
the degree of resorbing activity measured histologically correlates 
with serum immuno-assayable parathyroid hormone levels (Ellis, 1973). 
The low CA/TA values in this renal failure series are almost certainly 
also due to parathyroid activity, which is in line with their strong 
association with the degree of hypocalcaemia.
Similarly, the histological examination of trabecular bone from 
iliac crest showed a highly significant correlation between the fraction 
of available surface undergoing resorption and the degree of hypocalcaemia. 
Measurement of iliac crest cortical thickness however gave so wide a 
range of results as to be of no value. This was also the experience of 
Meunier (1967).
The state of secondary hyperparathyroidism that is a consequence 
of the hypocalcaemia should to some extent be mirrored by a reduced 
tubular reabsorption of phosphate. This is found in virtually all 
cases but what is perhaps surprising is that there is no relation 
between TmP and the degree of hypocalcaemia. There is normally a 
reciprocal relationship between serum calcium level and the concen­ 
tration of immuno-assayable parathyroid hormone (Berson & Yalow, 1966) 
and it might therefore be expected that the plasma calcium concentration 
would determine the TmP. That this is not the case may simply indicate 
that TmP is not an adequate indicator of parathyroid hormone levels or
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that circulating parathyroid hormone concentration in chronic renal 
failure is maximal for the degree of parathyroid hyperplasia in each 
case and does not directly reflect the degree of hypocalcaemia. 
Moreover, although on the one hand hypocalcaemia increases the drive 
to the parathyroid glands, it also reflects the parathyroid response, 
and the relation between plasma calcium and circulating parathyroid 
hormone levels would therefore represent a mixture of calcium-driven 
parathyroid hormone concentration and parathyroid hormone-driven calcium 
concentration. For this and other reasons (Berson & Yalow, 1971), no 
attempt was made to measure plasma parathyroid hormone level in this 
study.
There is almost certainly a causal relationship between the reduction 
in metacarpal cortical thickness and the hypocalcaemia, but weaker 
relationships also exist between the CA/TA ratio and the plasma alkaline 
phosphatase and bicarbonate levels. With regard to the alkaline phos- 
phatase, the quantitative bone histology clearly shows that the plasma 
concentration of this enzyme is a function of the bone forming surfaces, 
but not of resorbing sites. There cannot therefore be a direct connec­ 
tion between a resorbing process as measured by the CA/TA ratio and the 
alkaline phosphatase level, but an indirect one operating through the 
hypocalcaemia which is a feature of osteomalacia. It is likely that 
the association between the CA/TA and the degree of acidosis is similarly 
indirect and due to the relation of the latter to hypocalcaemia, since 
in the bone histology there is an inverse relation between the fraction 
of available surface undergoing resorption and plasma calcium but a 
weaker correlation was found between histological resorption and the 
plasma bicarbonate level. Using the technique of microradiography,
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Barzel and Jowsey (1969) suggested that acidosis created conditions 
in which bone resorption was increased, though the mechanism by which 
the effect might be operating was not discussed. The hypocalcaemia 
is therefore the most important single determinant of bone resorption, 
and it is necessary to consider some of the factors that determine 
plasma calcium level. 
Plasma calcium homeostasis.
The sources of plasma calcium are net absorbed calcium from the 
gut and net resorbecJ calcium from the bone. Calcium absorption is 
low in chronic renal failure and net absorption is generally about 
zero (Stanbury, 1968b)or may be negative (Table 7). There is a loose 
relation between absorption and plasma calcium (figure 26) but many 
of the low absorption cases were normocalcaemic. Furthermore, all 
plasma calcium estimations were made in the fasting state, so that 
in fact the plasma calcium is being maintained by bone resorption, and 
absorption cannot be the decisive factor in causing the hypocalcaemia 
when it occurs.
Net resorbed calcium is the difference between the rates of miner­ 
alisation and resorption. It may be argued that renal hypocalcaemia is 
the result of a failure to resorb bone at an adequate rate, and while 
this is true in a sense, it is an unsatisfactory explanation when the 
data on bone kinetics are considered. These data (figure 30) indicate 
that most patients with hypocalcaemia have high rates of bone resorption 
as determined by the combination of balance and isotope procedures 
and from the rate of urine hydroxyproline output. Moreover, since the 
patients all have a low GFR, the resorption rate relative to GFR is 
very high indeed. It is therefore impossible to argue that impaired
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bone resorption is the cause of hypocalcaemia. Why then is the plasma 
calcium low? One reason is that although the resorption is high, so 
is bone mineralisation and the calcium resorbed from some sites is 
therefore being redeposited in others. Accordingly, net resorption 
is not as high as might be expected. This is indicated by the fasting 
Ca/Cr values which reflect net bone resorption and which are never 
raised (figure 14). Nonetheless, net resorption should be sufficient 
to maintain normocalcaemia since the Ca/Cr is frequently in the normal 
range and the fasting Ca-, which is in fact net bone resorption 
relative to GFR, is in fact highest in the patients with hypocalcaemia.
The other regulator of plasma calcium is the renal tubular reabsorp- 
tion of calcium (Peacock & Nordin, 1953). When calcium is infused into 
normal individuals or patients with renal failure there is a positive 
correlation between plasma and urine calcium (figure 45), but it is 
a striking feature of this series of 50 patients in varying degrees of 
renal failure that there is a highly significant inverse correlation 
between fasting plasma and urine calcium when the latter is related to 
GFR (figure 16). The patients with hypocalcaemia tended to have a 
high rate of calcium excretion relative to GFR, and the normocalcaemic 
individuals generally excreted calcium at a normal rate relative to GFR. 
If there is a causal relation between these two phenomena, it can only 
mean that the hypocalcaemia is the result of a reduced tubular reab- 
sorption of calcium since it is impossible to conceive of any mechanism 
whereby hypocalcaemia could itself raise urine calcium. The fact that 
the absolute rate of calcium excretion is low in renal failure is of 
no relevance in this context. The absolute rate must govern the time 
taken to achieve the steady state, but it cannot determine the steady
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state itself. Plasma calcium is a function of the filtered load 
relative to GFR, and the Ca £ is calcium excreted relative to GFR. 
Using this mode of expression means that filtered load and excreted 
calcium are considered in the same terms and clearly illustrates 
the reduced tubular reabsorption of calcium that characterises the 
hypocalcaemic cases. A change in ultra-filtrable calcium by acidosis 
or decreased plasma proteins would have no lasting effect on the Car 
and could not explain these data. There is therefore a tubular leak 
of calcium in these hypocalcaemic patients and this is the most 
important reason for the hypocalcaemia.
It is known that metabolic acidosis can reduce the tubular reab­ 
sorption of calcium (Lemann et al. 1957} and the present data are 
consistent with this: correction of the acidosis in the patients 
studied by metabolic balances led to a fall in urine calcium in the 
fact of increased absorption; the patients with hypocalcaemia were 
more acidotic than those with normocalcaemia, and the plasma bicarbonate 
is inversely related to calcium excretion relative to GFR. To this 
extent, acidosis would seem to be contributing to the hypocalcaemia. 
However, it was not found possible to alter significantly the plasma 
calcium by changing the acid-base status of the balance patients, 
making careful observations over a two week period. This anomaly is 
accounted for by the effect of correction of the acidosis on the bone 
mineralisation rates, which rose significantly to absorb all the extra 
calcium that was retained.
The relationships between acidosis and plasma or urine calcium are 
more definite in the patients with raised alkaline phosphatase levels 
than in those without. This may simply mean that there is a group
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with metabolic acidosis who have not yet developed its complications, 
but this would be to presuppose that these complications take time 
to develop, which is unlikely to be true, for example, of the effect 
on the renal tubule. Such an effect might take days or weeks to 
appear but these patients had been in stable chronic renal failure for 
many months. It seems more likely that as the osteomalacic state 
develops, indicated by a rise in plasma alkaline phosphatase levels 
and reflecting an insufficiency of Vitamin D activity, the patient 
is more vulnerable to the effects of acidosis which in turn tend to 
aggravate the osteomalacic syndrome. Conversely, while Vitamin D 
metabolism remains adequate, the patient is generally protected against 
the effect of acidosis. A deficiency of active Vitamin D metabolites 
may be more critical if parathyroid gland sensitivity is reduced in 
this situation as Crtdham et al. (1973) have suggested.
There is no doubt of course that Vitamin D alone, if given in 
sufficiently large doses, will overcome the hypocalcaemia and the 
data in this study offer some explanation of the mechanism by which 
this takes place. Vitamin D obviously corrects the malabsorption 
of calcium but although this may make some contribution to calcium 
homeostasis improved absorption cannot be the most important factor 
since plasma calcium rises without simultaneous elevation of urine 
calcium, which may actually fall. This indicates an increased tubular 
reabsorption. Furthermore, since the urine calcium excretion is 
unchanged in the fasting state, increased net bone resorption cannot 
account for the correction of the hypocalcaemia. The results of the 
calcium infusions show that in the hypocalcaemic state there is an 
abnormally low renal threshold for calcium and this is corrected after
administration of suitable doses of Vitamin D. Were it not for this
change in threshold, the total rate of entry of calcium into the plasma
in order to sustain a normal serum level might have to be extremely
high, and this would be reflected in a similarly high urine calcium
excretion.
Alkaline phosphatase.
Osteomalacia, as evidenced by increased osteoid coating of trabe- 
culae and an abnormally low proportion of calcification fronts, is 
strongly associated with raised plasma alkaline phosphatase concentrations. 
The high isotopic bone mineralisation rates in these cases are due to 
the large number of mineralising sites in the skeleton as a whole, 
though activity at each individual site is decreased (Frost, 1967). 
Garner and Ball (1966) have shown that while the bone in renal osteo- 
malacia is under-mineralised, the total amount of bony tissue is frequently 
so great that the absolute quantity of mineralised trabecular bone may 
sometimes be at the upper limit of or greater than normal. This is 
true of many of the biopsies in the present series (Table 14). Since 
the patients are seldom in positive overall balance, this gain in 
mineral by the trabeculae must take place at the expense of compact bone. 
Furthermore, the trabecular bone of the spine and iliac crest is resistant 
to resorption because of its osteoid cover* which in turn reflects its 
high intrinsic rate of turnover. The apparently dense radiological 
appearance of the spine in many of the osteomalacic cases may be 
explained on these grounds. Cortical bone, which turns over more slowly 
(Fletcher et al. 1965) developing less osteoid, is more available for 
resorption and is mobilised in response to hypocalcaemia. Thus the 
overall process is a transfer of mineral from cortical to trabecular
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bone at a continuing low plasma calcium concentration determined by 
renal tubular function.
What are the factors that influence the development of osteomalacia? 
It has been commonly thought that a low calcium-phosphate product is 
at least in part responsible and this concept continues to find support 
in one form or another. The emphasis on the bone resorbing activity 
of the metabolites of Vitamin D and the failure to find a direct anabolic 
effect (Raisz et al. 1972; Reynolds, 1973) has again led to the 
suggestion that mineralisation is essentially a passive process. Thus 
Anderson and .Reynolds (1973) state that microcrystals extruded from 
the osteoblast act as nucleating sites for appatite provided the ECF 
is saturated with respect to the salt, ar.d it is believed that Vitamin D 
simply ensures that the calcium and phosphorus are made available at 
the bone forming surface. The general concept is supported by the work 
of Baylink (Stauffer et al. 1973) who showed that histological osteo­ 
malacia could result from hypocalcaemia alone, and while Vitamin D 
increased the osteoclastic population there was no detectable effect 
on the degree of osteomalacia. However, any theory which depends in 
the final analysis upon the ionic product of the bathing fluid deter­ 
mining calcification is difficult to accept in the light of clinical 
experience (Stanbury, 1967) even when the prevailing pH is taken into
account.
An alternative hypothesis maintains that all material in contact 
with the bone has to pass across a cell membrane (Baud, 1968; Canas 
et al. 1959) in which case a moderate fall in the concentration of 
calcium in the ECF would be unlikely to have any significant effect 
on the rate of transport across the cell. This is because the
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intracellular calcium concentration is kept extremely low, in the
-4 
region of 10 mM (Talmage, 1969) so that the calcium gradient into
the cell is always very large. Using electron microscopy, however, 
Reynolds doubts the universal existence of this cell envelope to bone 
(Reynolds, 1974).
A third concept, based upon sound experimental data and entirely 
consistent with the observations of many workers, goes further toward 
explaining the process of bone mineralisation than any of the earlier 
suggestions. According to this theory, intracellular vesicles appear 
in the neighbourhood of the Golgi apparatus of the bone forming cell, 
(Aaron & Pautard, 1973a,b; Aaron, 1973) and begin to accumulate amorphous 
calcium phosphate. These vesicles are subsequently extruded from the 
cell into the surrounding osteoid (Anderson, 1969; Bonucci, 1971) and 
may continue to take up mineral from the bathing fluid (Ali et al. 1970). 
There is wide agreement on these views but Aaron and Pautard believe 
that the bone forming cell undergoes a cycle of activity in which it 
loads up with mineral, packages it in the vesicles and these are then 
jettisoned into the surrounding matrix (Aaron & Pautard, 1973a). These 
authors believe that mineralisation takes place as more and more vesicles 
are extruded into the loosely arranged osteoid. There is also evidence 
that these young osteocytes can accumulate and distribute calcium 
without phosphorus, and possibly phosphorus without calcium, into the 
adjacent matrix. The concepts of Pautard and Aaron as based upon the 
use of high resolution light microscopy and time-lapse cinephotography 
in living systems and probably avoid a number of artefacts introduced 
by conventional fixation techniques, and moreover require no assumptions 
about the effects of the mineral concentration of the bathing fluid.
At what stage, if any, is Vitamin D involved in these processes? 
It seems reasonable to suppose that Vitamin D affects calcium transport 
into bone in a way analogous to the one by which it regulates transport 
at other sites and yet experimental evidence has tended to suggest that 
it is without a direct action on calcification of osteoid (Stauffer 
et al. 1973; Reynolds, 1973). Nonetheless de Luca (Omdahl et al. 1971) 
has stated that 25-hydroxycholecalciferol may have more anti-rachitic 
activity than the 1,25-dihydroxy metabolite in spite of the latter's 
greater calcaemic action, implying that there may be an unidentified 
metabolite with a trophic effect on bone. Moreover, Anderson (1974) 
reported that matrix vesicles appeared to contain relatively little 
mineral in the rachitic state, though it is impossible to tell whether 
this was due directly to the absence of the vitamin or to the associated 
hypophosphataemia. Experience with bone histology (Frost, 1963; 
Rasmussen & Bordier, 1973) has led to the suggestion that bone resorption 
at any particular site precedes, and is followed by, formation t and 
Bay1ink(197Q) has shown that Vitamin D induces differentiation of 
resting cells into osteoclasts, so that is possible that the whole 
process of bone turnover is under the control of this hormone.
None of these views involve the acid-base status of the tissue 
fluid, and yet the data in the present work imply that acidosis can 
contribute to the osteomalacia. A highly significant relation exists 
between the fraction of surface covered by osteoid and the degree of 
acidosis, and histological osteomalacia is rarely seen in patients 
protected against acidosis. An important feature of the treatment of 
acidosis in cases of renal csteomalacia was the increase in isotopic 
bone mineralisation rate, suggesting that acidosis can slow the process
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of calcification. In this procedure, administration of bicarbonate 
resulted in a rise in blood pH and, to a variable extent, the pC02 . 
Barzel (1971), in an in vitro experiment, cultured rat bone explants 
and varied the pH of the medium by altering the pC0 2 . It was noted 
that a mild degree of acidosis (pH 7.2) was sufficient to reduce bone 
accretion in this system. Though the experiment should obviously be 
repeated with the pH varied at a constant pCO-, it is broadly in 
line with the observations in the present study. In acidotic rachitic 
rats given a small single dose of 25-hydroxycholecalciferol there was 
significantly reduced healing compared with non-acidotic controls 
treated the same way. By what mechanism could acidosis be affecting 
bone formation? A direct effect on Vitamin D metabolism seems unlikely 
(see p. 84) and Norman et a 1. (1973) have Investigated the hydroxylation 
step leading to synthesis of 1,25-dihydroxycholecalciferol. This takes 
place at an optimum pH 7.4, but the reaction is only slightly impaired 
by degrees of acidosis which would be regarded as clinically severe, 
and the contribution cf this effect cannot be considered important in 
the present context.
It is highly relevant however that matrix vesicles have been 
isolated and shown to accumulate calcium in vitro by an energy dependent 
process, and this effect i^ critically sensitive to pH in the physio­ 
logical range with marked uptake of calcium at pH 7.4, but almost no 
activity at pH 7.2 (Ali & Evans, 1973). These values correspond closely 
with those of the metabolic balance patients before and after correction 
of their acidosis. The relation between calcium uptake by the vesicles 
and pH is strikingly similar to the variation of alkaline phosphatase
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activity with pH, and the vesicles contain this enzyme in large 
quantities (Ali et al. 1970). If alkaline phosphatase is important 
in bone mineralisation, it might be expected that this would be 
enhanced by physiologically slightly alkaline conditions, and in the 
experiment of Barzel (1971) this is what was found. Holdsworth et al. 
(1970) and Russell et al. (1972) made the interesting suggestion that 
the calcium ATPase in gut might be an alkaline phosphatase. This species 
of enzyme is difficult to work with due to its heterogeneity, its 
instability when isolated, and its lack of antigenicity (Reynolds, 1974). 
Furthermore, its catalytic properties require it to be in a dimeric 
form (Chappelet-Tordo et al. 1974). Nonetheless, in a clear and detailed 
series of experiments Birge and Gilbert (1974) succeeded in showing that 
certain of the intestinal alkaline phosphatases are highly specific 
calcium ATPases. Such enzymes are likely to constitute a pH-sensitive 
step in energy-dependent calcium translocation in the gut, and if this 
is the case at other sites of calcium transport it would provide a 
simple explanation for the association between metabolic acidosis and 
the inhibition of bone mineralisation which characterises rickets and 
osteomalacia.
TABLES
Figure 47. X-rays on Case 1.
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APPENDIX
Case I
A.S. Male 1^ years
Patient investigated at 1 year because of failure to thrive, 
thirst and polyuria. Food was rejected and only milk taken. Examin­ 
ation showed a pale, hypotonic child with mental retardation. 
Radiological examination showed dense cortical bone with irregular 
diaphyses (figure 47) and periostea! calcification. Investigations 
were:
Plasma urea 161 mg/100 ml 
Plasma calcium 11.2 mg/100 ml 
Plasma phosphate 6.2 mg/100 ml 
Plasma Alkaline phosphatase 11 KA units/100 ml 
Blood pH 7.31
Parathyroid hormone level - not detectable. 
Urine phosphoethanolamine - not detectable. 
Renal biopsy: microscopic interstitial calcification. 
Progress: the patient was given a low calcium diet and 
the hypercalcaemia cleared and the urea fell to 51 mg/100 ml. There 
was no benefit from vitamin supplements until ergocalciferol 1,000 
i.u./day was introduced.
Case II
L.C. Male 43 years^.
Patient gave a 12 year history of fracture with mild trauma,
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episodes of spontaneous pain in the back and loss of about 12 cm 
height. Over a 3 year period, severe hip-muscle weakness had 
developed. No family history of bone disease. Examination showed 
evidence of thoracic and lumbar vertebral body collapse. There was 
a proximal myopathy (hips and shoulders). X-rays showed multiple 
vertebral body fractures and Looser zones in the femora and pubic rami. 
Investigations were:
Normal haematological picture, urea, electrolytes and 
plasma proteins.
Plasma calcium 9.9 mg/100 ml
Plasma phosphate 0.9 mg/100 ml
Plasma Alkaline phosphatase 20 K.A. units/100 ml
Urine calcium 176 mg/24 h
Urine phosphorus 722 mg/24 h
Urine hydroxyproline 68 mg/24 h
TmP 1.2 mg/100 ml GF
There was poor calcium absorption and negative calcium balance, 
but phosphate absorption was normal despite the low renal threshold, 
.'iac crest biopsy showed thick irregular under-mineralised bone 
covered with wide osteoid borders. Fraction of bony tissue: 36%. 
Fraction of surface covered by osteoid: 96%. No calcification fronts 
and no tetracycline bands.
Progress: the patient was given an 7 day phosphate infusion 
and oral supplements for 5 weeks during which time the plasma phosphate 
ranged from 1.6 to 3.2 mg/100 ml. Following this, iliac crest bio^y 
showed areas of patchy mineralisation within the osteoid but essentially
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little change. Calcifications fronts were absent and tetracycline 
labelling was patchy or diffuse. X-rays suggested some mineralisation 
around Looser zones but this was not incontrovertible.
Case III
R.D. Male 3 years.
Patient investigated at 2 years because of thirst and polyuria 
and found to have a congenital absence of the left kidney and an 
aperistaltic segment in the right ureter with proximal obstruction. 
Examination showed an active child without muscle weakness. Rickets 
was present (skull, costo-chondral junction, wrists) as confirmed by 
x-ray. 
Investigations shows:
Plasma urea 125 mg/100 ml
Plasma bicarbonate 13 mg/100 ml
Plasma calcium 9.3 mg/100 nl
Plasma phosphate 6.9 mg/100 ml
Alkaline phosphatase 22 K.A. units/100 ml
Progress: the ureteric obstruction was corrected and the 
plasma urea and phosphate decreased slightly (105 mg/100 ml and 5.0 mg/ 
100 ml respectively). Plasma calcium and electrolytes were unchanged, 
hypocalcaemia never being seen. Though the patient was acidotic, the 
urine could reach pH 5.4. However, alkali supplements (50 mEq/day) 
failed to correct completely the acidosis. A bicarbonate infusion 
showed the presence of a reduced bicarbonate threshold suggesting a 
predominently proximal tubular defect.
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The rickets was successfully treated with ergocalciferol 10,000 
i.u./day and alkali 40 mEq/day.
Case IV
HBa Female 61 years.
Patient investigated at 52 years for recurrent attacks of acute 
pyelonephritis, with right nephrectomy carried out at 53 years. At 
60 years patient developed severe hip-girdle weakness, the only 
abnormality noted clinically. X-rays showed osteoporosis but not 
osteomalacia. 
Investigations were:
Plasma urea 90 mg/100 ml
Plasma bicarbonate 17 mEq/L
Plasma calcium 7=0 mg/100 ml
Plasma phosphate 3.6 mg/100 ml
Plasma alkaline phosphatase 45 K.A. units/100 ml
Blood pH 7.25
M.S.U. Persistent pyuria. Sterile.
Urine calcium 45 mg/24 h
Lowest urine pH 5.6
Urine ami no-acids - normal
Progress: a balance study showed zero calcium balance, and 
no evidence of malabsorption syndrome. The acidosis was corrected and 
slight improvement of the balance occurred entirely due to absorption. 
When ergocalciferol 50,000 i.u./day was given in addition, absorption 
increased further, and urine calcium fell. The plasma calcium rose
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to normal levels, and plasma phosphorus rose slightly. A bicarbonate 
infusion showed the presence of a slightly reduced bicarbonate 
threshold.
APPENDIX
Specimen 
number
Urine 1
2
3
4
5
6
7
Plasma 1
2
3
Number of 
estimations
10
10
10
10
10
10
10
2
2
2
Mean 
Calcium S.E.M. 
mg/100 ml
17.87 0.21
14.15 0.18
26.66 0.33
11.22 0.14
7.70 0.08
4.90 0.03
4.40 0.03
7.60 0.00
8.25 0.05
10.20 0.10
Mean 
phosphorus S.E.M. 
mg/100 ml
58.66 0.50
47.20 0.32
49.72 0.40
50.60 0.56
16.90 0.23
50.11 0.53
64.40 0.56
2,45 0.05
2.70 0.00
6.45 0.05
Mean 
creatinine S.E.M. 
mg/100 ml
100.22 1.57
70.40 0.85
80.90 1.05
64.90 0.82
45.80 0.53
89.90 1.23
43.40 0.52
2.05 0.05
2.05 0.05
13.25 0.05
TABLE 1. Reproducibility of Auto-Analyser methods.
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Variables
CA/TA and log alkaline 
phosphatase
Plasma Ca and log 
alkaline phosphatase
Plasma HCG3 and log 
alkaline phosphatase
CA/TA and plasma Ca
A CA/TA and plasma Ca
CA/TA and plasma HCO,
A CA/TA and plasma 
HC03
Plasma Ca and plasma Cr
Car and plasma Ca
Car and plasma HCO-
Plasma Ca and plasma 
HC03
Plasma Ca and plasma P
Plasma Ca and plasma 
albumin
Plasma Ca and plasma 
proteins
Plasma P and plasma Cr
Pr- and plasma P 
TmP and plasma Ca
TmP and plasma HC03
o-j and plasma HC03
OHP and resorption rate 
(all data)
OHP and resorption rate 
(alkali treatment)
Number 
of 
Cases
45
48
48
45
45
45
45
50
50
50
50
50
36
36
50
50 
50
50
41
17
11
r
-0.50
-0.45
-0.23
0.41
-0.51
0.29
-0.34
-0.26
-0.46
-0.45
0.38
-0.22
-0.10
0.23
0.83
0.92 
0.11
0.17
0.47
0.79
0.96
P
<0.001
=0.001
n.s.
<0.01
<0.001
=0.05
<0.05
n.s.
<0.001
<0.001
<0.01
n.s.
n.s.
n.s.
O.001
O.001 
n.s.
n.s.
<0.005
<0.001
<0.001
TABLE 5. Correlation coefficients for biological 
data of patients.
MALES
Patient
OR
Pha
BC
JBa
JG
PH
JP
FC
EA
JBo
NS
FB
HH
RS
EBr
Age
yr.
21
25
26
29
37
42
44
46
50
51
53
53
54
55
63
MTW 
cm.
0.84
1.02
0.99
0.82
0.99
1.14
0.94
0.91
1.10
1.02
0.91
1.01
0.94
1.00
0.91
Normal 
CA/TA mean 
S.D.
0.79 0.706
0.56 0.125
0.80
0.78
0.69
0.67 0.710
0.58 0.126
0.71
0.60 0.697
0.74 0.148
0.74
0.60
0.63
0.72
0.71 0.693
0.111
FEMALES
Patient
SC
BB
MH
JH
TT
MSm
JH
IP
EBa
JWe
KC
LA
Age
yr.
15
23
27
29
34
42
44
48
51
51
61
62
MTW 
cm.
0.76
0.64
0.71
0.69
0.86
0.78
0.83
0.79
0.87
0.76
0.86
0.73
Normal 
CA/TA mean 
S.D.
0.70 0.760
0.71 0.122
0.74
0.85
0.68 0.778
0.118
0.68 0.757
0.55 0.108
0.76
0.77 0.697
0.71 0.130
0.57 0.633
0.54 0.133
TABLE 6. Bone X-ray data of the patients, with the normal values for the 
corresponding age and sex. Data from patients with normal alkaline 
phosphatases.
MALES
Patient
PI1
JM
SK
LB
MS
HC
JD
Age
yr.
18
18
43
54
54
61
67
MTW 
cm.
0.77
0.82
0.89
1.01
1.03
0.97
0.94
Normal 
CA/TA mean 
S.D.
0.57 0.706
0.63 0.1215
0.51 0.710
0.126
0.58 0.697
0.49 0.148
0.39 0.693
0.54 0.111
FEMALES
Patient
LD
GP
CW
MG
TB
MS
HBa
ESa
VS
Age
yr.
15
17
18
44
55
61
62
69
73
MTW 
on.
0.58
0.72
0.75
0.78
0.89
0.80
0.78
0.82
0.72
Normal 
CA/TA mean 
S.D.
0.66 0.760
0.52 0.122
0.79
0.85 0.757
0.108
0.46 0.697
0.130
0.59 0.633
0.59 0.133
0.52
0.33 0.587
0.114
TABLE 6 continued. Bone X-ray data of the patients, with the normal values 
for the corresponding age and sex. Data from patient with raised alkaline 
phosphatases
Plasma bicarbonate 
Plasma calcium
Normal alkaline
phosphatase
group
(31)
20.1
9.35
Raised alkaline
phosphatase
group
(19)
16.3
8.00
2.89 <0.01 
4.62 <0.001
TABLE 7. Plasma bicarbonate and calcium in patients with normal and 
raised alkaline phosphtase levels
Normal Alkaline
Phosphatase
Plasma
4->
c
O)
•r—
4->
«J
O.
RD
PHm
JG
OP
FC
JBo
NS
FB
HH
RS
EBr
SC
BB
MH
TT
MSm
OWi
IP
EB
JWe
KC
LA
Mean
S.D.
E*1
3O
•i-CD
Or­
es cr>
OE
9.8
9.3
10.0
9.2
10.3
9.4
8.7
10.0
9.7
9.2
8.7
9.8
8.9
9.8
9.3
9.5
9.5
10.1
9.4
10.2
10.7
9.3
c 1•r—
E 0
3 O
.0 r-
5 CD
4.3
3.8
4.3
4.7
4.1
3.2
4.3
4.6
3.1
3.6
3.3
4.6
4.0
3.9
4.2
4.6
4.2
4.0
3.8
4.3
3.7
4.1
4.03
0.45
c•r—
O) 
40
8_
0. E
r— CD
1C O
4J .—
0 ^.
r— CD
8.1
5.6
7.3
7.3
7.7
6.5
6.7
7.5
5.2
6.3
7.7
8.4
6.8
6.9
6.5
7.5
6.4
7.5
6.6
7.3
7.8
6.8
7.06
0.69
Raised Alkaline
Phosphatase
Plasma
-»->
c
0)•P—
4J
to
C_
PM
JM
SK
LB
HG
HC
JD
LD
CW
RB
TB
MSt
HBa
ESa
*E
1 0••- CD
0 •—
r— "~^
<a o>
o E
5.9
9.0
7.1
9.0
6.3
7.5
10.0
7.7
7.4
9.0
8.9
8.6
7.0
8.2
r_
c E
•r—
E 0
3 O
J3 r—
f i 11 *^s^
«C 0
3.9
3.2
4.4
4.7
4.8
4.2
4.0
4.5
4.3
4.0
4.5
4.5
4.3
4.2
4.24
0.43
c
5
40s_
0. E
r— O
ro O
4-> r—
O *^
H= CO
6.1
6.2
7.6
7.8
7.5
6.0
7.6
8.3
6.2
7.1
6.5
7.2
7.3
8.0
7.10
0.76
TABLE 8. Plasma calcium and protein concentrations 
of the patients
•M
Co>•r—
4-*
IB
(X
HBa
WB
MSt
LD
JW
ESa
PM
CW
TF
LA
GP
HC
IP
MH
RS
JP
AC
«*
"^Xfc
E <U JQ
3 O
•r- C O>
0 <0 -ii
i — • r— *"*-»
fO fO £J)
0 _Q £
+0.9
+4.7
-1.7
-9.6
-0.1
-4.3
-5.0
+0.8
-2.0
-1.7
-5.0
-0.5
+0.2
+0.6
-1.5
-1.3
+0.6
r-*
E E
<0 3 O
E T- O
(A Or—
fO »~* ^^^
r— RJ D>a. o E
7,2
8.8
8.6
7.0
9.3
8.3
6.0
7.1
9.9
9.5
7.0
5.9
9.1
10.0
9.2
9.2
9.7
<u
ro
Co
«O J3
E S- — 1
l/j flj ^^^
ro O O"r— ••- UJ
0-.Q E
19
16
10
17
15
19
16
12
18
12
14
16
23
19
18
21
20
aj
C r—
•r- E
lO'^™1 f"">
E4J 0
c/l ro ,—
ro <U -^
i — J- cn
0.0 E
2.8
4.1
4.6
4.1
15.5
1.4
6.0
13.5
8.0
6.2
16.6
7.7
5.1
16.5
4.6
18.4
11.3
TABLE 9. Balance state of patients showing 
biochemical data
Patient
Pil
DH
LD
CU
MSt
LA
PM
DM
LD
CU
MSt
LA
Normal 
Range
Blood 
pH
7.30
7.19
7.29
7.24
7.15
7.25
7.44
7.43
7.36
7.40
7.29
7.38
7.37- 
7.40
Blood 
pC02
mm Hg
27
32
34
29
27
26
36
36
39
42
34
34
35- 
42
Plasma 
Ca
mg%
6.0
8.2
7.4
7.1
8.6
9.5
6.5
8.3
7.6
6.1
8.3
9.3
8.9- 
10.4
Plasma 
P
mg%
TmP
mg/lOOml
G.F.
PRE --TREATMENT
4.8
10.0
4.6
8.9
3.9
4.9
0.6
1.0
0.9
1.2
0.9
1.0
POST-TREATMENT
3.6
6.6
4.1
8.2
3.3
4.2
2.5- 
4.0
0.4
0.0
1.2
1.1
0.6
0.6
2.2- 
4.2
Plasma 
Alk.
Phosphatase
K.A. units/
100ml
38
128
40
82
103
8
29
116
46
79
114
9
4-11
Creatinine 
Clearance
ml/min
6
11
9
5
10
8
7
13
10
7
9
7
70-120
Calcium 
Balance
mg/kg
bw/day
-5.97
-0.75
-9.60
0.85
-1.61
-1.74
-1.41
1.25
-3.58
0.22
-0.75
-0.22
-2.0- 
2.5
TABLE 10. The effect of treatment with alkali on biochemical and balance status of 
six patients with renal acidosis.
Patient
WB
MH
RS
JHi
LA
AC
TF
TP
IP
HBa
FS
HC
GP
CD
PM
CW
MSt
Normal range
Mineralisation
rate, 
mg Ca+Vkg/day
29.40
13.40
5.01
3.22
4.82
8.40
15.07
10.69
19.43
7.05
9.30
19.70
15.54
22.77
11.50
49.80
16.50
3-7
Resorption
rate , 
mg Ca++/kg/day
22.30
13.43
7.16
6.98
6.47
9.78
16.54
12.15
19.50
5.59
11.47
20.14
18.31
28.91
15.52
51.20
16.97
1-9
Urine
hydroxyproline 
mg/kg/day
0.80
0.22
0.37
0.24
0.55
0.20
0.50
0.71
0.93
0.80
0.32
0.76
0.46
1.30
0.75
0.12
0.76
0.10-0.40
Plasma
calcium, 
mg/100 ml
10.0
9.8
9.2
9.5
9.3
9.9
9.9
9.2
9.2
7.0
8.2
7.5
6.7
7.7
5.9
7.4
8.6
9.0-10.8
Alkaline
phosphatase, 
KA
units
6
7
8
8
8
9
9
10
17
25
34
38
39
40
41
82
103
<12
TABLE 11. Bone turnover and urine hydroxyproline in patients with chronic renal failure.
Patient
PM
DH
L.D
CW
MSt
LA
Normal 
Range
PRE-TREATMENT
Mineralisation 
rate
(mg/kg bw/day)
11.5
208
22.8
49.8
16.5
4.8
3-7
Resorption 
rate
(mg/kg bw/day)
17.5
209
32.4
49.0
18.1
6.6
1-9
24-hr, total 
urine
hydroxyproline 
(mg/kg bw/day)
0.75
-
1.30
1.20
0.76
0.55
0.10-0.40
POST-TREATMENT
Mineralisation 
rate
(mg/kg bw/day)
17.0
336
27.3
75.5
14.0
6.2
3-7
Resorption 
rate
(mg/kg bw/day)
18.4
335
30.9
79.3
14.8
6.4
1-9
24-hr, total 
urine
hydroxyproline 
(mg/kg bw/day)
1.08
7.40
1.40
1.79
1.54
0.63
0.10-0.40
TABLE 12. The effect of alkali on bone mineralisation and resorption rates and urine hydroxyproline.
Patient
PM
DH
LD
CW
MSt
LA
P%ise in 
mineral isation 
rate 
(mg/kg b.w/day)
R.5
126
4.5
25.7
-2.5
1.4
Rise in 
calcium balance 
(mg/kg b.w/day)
4.6
2.0
6.0
1.6
0.8
1.5
TABLE 13. The change in bone mineralisation 
rate and calcium balance after treatment 
with alkali
blent
3Ca
JBo
JWi
SWa
SLe
RLa
OWh
DPa
MKy
TBe
JCo
SDa
MS a
MMu
HSp
JBu
PMa
HCh
CWa
MSt
DHe
Normal
Range
Osteoid 
Surface %
15
11
37
23
26
37
2
50
86
30
33
77
47
18
80
87
73
95
73
96
70
2-
26
Resorbed 
Surface % 
Total
8
14
17
8
15
4
19
29
5
30
23
11
22
14
3
12
23
4
4
3
16
1-
10%
Resorbed 
Surface % 
Available
9
16
27
9
20
7
19
58
33
43
33
47
42
17
15
93
85
80
15
75
56
1-
14%
Calcification 
Front % 
Osteoid
t—
-
-
-
55
-
-
.
-
21
-
-
-
-
-
13
10
19
11
14
40
>60
Volume 
Bone Tissue 
% Total
23
15
21
21
28
30
21
28
29
22
27
28
24
36
23
24
26
43
27
17
28
15-
30
Plasma 
Calcium 
mg/lOOml
9.7
9.8
9.3
9.3
10.0
9.9
9.3
7.8
7.0
8.8
10.0
7.6
6.8
9.7
9.8
6.5
6.0
5.9
7.1
8.6
7.1
9.0-
10.8
Plasma 
Bicarbonate 
mEq/L
25
24
13
14
20
19
28
25
18
17
23
16
14
17
12
10
16
16
19
10
12
23-
28
Plasma 
Creatinine 
mg/ 100ml
8.4
6.0
15.5
10.8
2.5
3.7
8.8
11.0
9.8
8.1
10.0
6.0
5.2
19.0
3.7
10.0
6.0
7.7
13.5
4.6
9.8
0.7-
1.3
Plasma 
Phosphorus 
mg/ 100ml
6.0
4.3
7.0
10.0
3.9
4.1
4.2
5.3
5.6
4.0
6.8
4.7
7.2
12.0
3.8
8.3
5.9
4.0
8.4
3.8
9.8
2.5-
4.0
Plasma 
Alkaline 
Phosphatas 
KA units
8
8
8
8
10
11
11
14
14
18
19
20
21
24
25
27
48
60
83
105
128
<12
TABLE 14. Bone histology data on patients in chronic renal failure
Variables
Osteoid surface (% total) 
and plasma Ca
Osteoid surface (% total) 
and plasma HCO,
Resorbed surface (% total) 
and plasma Ca
Resorbed surface (% total) 
and plasma HCO^
Resorbed surface 
(% available) and 
plasma Ca
Resorbed surface 
(% available) and 
plasma HCO,
Number 
of cases
21
21
21
21
21
21
r
0.71
0.64
-0.02
0.29
-0.75
-0.44
.
p
<0.001
<0.001
n.s.
n.s.
<0.001
<0.05
TABLE 15 Correlation coefficients for bone histology data 
and plasma biochemistry in patients with renal 
failure
PRE-TREATMENT
Group C
V» C 
r— 3r— O 
_ E t~ E ¥ 
E 0 i— <0 3 Q H3.C O -r- 
TJ E-r- O E Q-O 13 <U O </» O r— l/lin r— S-S- 
O (Or— ~v» rtJO^ 3 O r— IE i— <O Ol r— .C CD O Ucia a. (x < j £= a. Q. E ca i/>
7.36 10.9 8.7 0 
7.36 10.4 5.9 1.5 
7.35 10.1 6.1 2.5 
7.34 10.0 7.3 0 
7.33 10.5 6.8 2.0 
7.37 10.0 6.7 0 
7.34 10.7 7.9 1.5 
7.33 10.4 5.7 1.0 
1.0
Mean 7.35 10.5 6.9 1.2 
S.D. 0.02 0.3 1.0 0.9
Group A
(/> C 
i— 3i— O 
E S- E r- 
E O r- 
<T3 3 O <O _C O T- 
T3 S ••- O E CLO -O O» O l/)Oi — tooii — L.L. 
O <Ur-^ (T3C3-^ 3O>~ nz i — (ocn r— x: 01 ouQ5Q. O-Og O.CXE OQCO
7.24 10,4 6,2 0 
7.26 10.3 7.4 0 
7.25 10.7 5.1 1.0 
7.00 9.5 4.9 0 
7.32 9.6 7.5 0 
7.19 9.8 8.0 0 
1.0 
0.5 
2.0
7.21 10.1 6.5 0.5 
0.11 0.5 1.3 0.7
POST-TREATMENT
Group C
(/> C 
r- 3 f— O 
_ E t- E r-
E O r- 
(TJ 3 O IB J= O T-E-«-o EQ.O -OQJV/»Or— l/)l/1i — 1- i- 
fOr— *»^ (OO~^. 3O r— IB O> r— _£T CT> OOQ.OE O.Q.E oaui
11.5 11.4 4.0 
11.5 11.5 4.5 
10.0 10.3 5.0 
10.1 11.6 4.5 
10.2 9.4 6.0 
11.4 11.1 5.5 
11.3 9.5 6.0 
10.8 10.3 4.0 
10.1 9.6
10.8 10.5 4.9 
0.7 0.9 0.8
Group A
CO C 
r— 3 r— OE v. E r-
(O 3 O n J= O '•<- 
E -r-0 E 0.0 -0 0) tOOr— </)(/)r— l-i. 
(O r— ^N. <OO^x 3O 
r- nj O) r— ^T Ol O O 
Q.OE O.Q.E OQtO
10.6 11.9 2.5 
9.6 10.5 2.0 
9.8 9.5 3.0 
10.6 9.3 1.5 
11.6 11.5 0 
10.4 12.9 1.5 
10.0 9.3 6.5 
11.3 9.6 3.5 
10.5 11.3
10.5 10.6 2.6 
0.7 1.3 1.9
TABLE 16. The influence - acidosis on the healing of experimental rickets in the rat.
Significance of difference between Groups C and A
with respect to
Blood pH
Bourdi 11 on Score 1
Plasma Calcium 1
Plasma Phosphorus 1
Bourdi 11 on Score 2
Plasma Calcium 2
Plasma Phosphorus 2
V
12
16
12
12
14
16
16
t
3.53
1.73
1.50
0.59
3.22
0.89
0.22
P
<0.005
n.s.
n.s.
n.s.
<0.01
n.s.
n.s.
TABLE 17. Influence of acidosis on the healing of 
experimental rickets in the rat: 
analysis of data
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